ML20212Q277
| ML20212Q277 | |
| Person / Time | |
|---|---|
| Site: | Wolf Creek  |
| Issue date: | 06/30/1986 |
| From: | Koester G KANSAS GAS & ELECTRIC CO. |
| To: | Martin R NRC OFFICE OF ADMINISTRATION (ADM), NRC OFFICE OF INSPECTION & ENFORCEMENT (IE REGION IV) |
| References | |
| 3, KMLNRC-86-157, NUDOCS 8609040140 | |
| Download: ML20212Q277 (74) | |
Text
. - _ _
l Wolf Creek Generating Station Docket No: STN 50-482 l Facility Operating License No: NPF-42 SIMIAISKIAL RADIOIDGICAL EFFLUFNr RELEASE REPORT I
Report No: 3 Reporting Period: January 1, 1986 through June 30, 1986 4
Subnitted by:
., Kansas Gas and Electric Company 8609040140 860630 PDR ADOCK 05000482 PDR R
16, Y \ l\
INTRODUCTION tis' Semiannual Radiological Effluent Release Report covers the period of January 1, 1986, through June 30, 1986, and satisfies the requirements
- specified in Technical Specification 6.9.1.7. ,
4 i Section I provides a sunnary of the quantities of radioactive liquid and
! gaseous effluents for this reporting period. We format is similar to that provided in Regulatory Guide 1.21, Revision 4. An elevated release pathway does not exist at Wolf Creek Generating Station. W erefore, all airborne releases are considered to be ground level releases. A conservative error of thirty percent has been estimated in effluent data. %ere was one shipnent of solid waste during this reporting period.
Section II provides Supplemental Information as described in Regulatory Guide 1.21, Revision 4.
Section III provides additional information required by Technical
- Specification 6.9.1.7.
a t-4 4
4
.l I
i
, -7 , , - .,. , __.-y_, , . , ,-_ .-_._. _ , , ,_. yy. ,- _
- . , , , . , _ . _ _---_._,_m,,,
SECTION I Year 1986 REPORT OF RADIOACTIVE EFFLUEtTPS: LIQUID Quarter Quarter Unit 1 2 A. Fission and Activation Products
- 1. Total Release (not including tritium, gases, alpha) Ci 1.81E-01 1.93E+00
- 2. Average diluted concentration during period uCi/ml 1.59E-08 3.52E-07
- 3. Percent of Applicable Limit % 3.63E+00 3.86E+01 B. Tritium
_1_., 'ibtal Release Ci 1.29E+02 1.08E+02
- 2. Average diluted concentration during period ~ uCi/ml 1.10E-05 2.05E-05
- 3. Percent of Applicable Limit % 3.67E-01 6.83E-01 C. Dissolved and Entrained Gases
- 1. Total Release Ci 1.69E-01 8.66E-01
- 2. Average diluted ccncentration during period uCi/ml 1.45E-08 1.58E-07
- 3. Percent of Applicable Limit % 7.25E-03 7.90E-02 D. Gross Alpha Radioactivity
- 1. Total Release Ci 0.00E+00 0.00E+00 E. Volume of waste released liters 3.65E+06 3.97E+06 F, Volume of dilution water used liters 2.35E+10 2.10E+10 Page 1 of 16
Year 1986 LIQUID EFFLUENTS Continuous Mode Batch Mode NUCLIDES Quarter Quarter Quarter Quarter RELEASED Unit 1 2 1 2
'l H-3 Ci 0.00E+00 0.00E+00 1.29E+02 1.08E+02 Na-24 Ci 0.00C+00 0.00E+00 5.52E-04 1.49E-04 Cr-51 Ci 0.00E+00 0.00E+00 4.01E-02 2.98E-01 Mn-54 Ci 0.00E+00 0.00E+00 3.69E-03 2.29E-02 Fe-59 Ci 0.00E+00 0.00E+00 3.35E-03 3.72E-02 00-58 Ci 0.00E+00 0.00E+00 7.53E-02 1.42E+00 C0-60 Ci 0.00E+00 0.00E+00 4.70E-03 3.91E-02 Zn-65 Ci 0.00E+00 0.00E+00 1.04E-05 1.21E-03 Rb-88 Ci 0.00E+00 0.00E+00 2.18E-05 5.09E-04 Zr-95 Ci 0.00E+00 0.00E+00 7.00E-03 2.83E-02 Zr-97 Ci 0.00E+00 0.00E+00 3.28E-05 2.65E-04 Nb-95 Cl 0.00E+00 0.00E+00 9.16E-03 3.76E-02 Mo-99 Ci 0.00E+00 0.00C+00 2.61E-03 1.08E-02 Tb-99M Ci 0.00E+00 0.00E+00 2.01E-03 1.01E-03 Ru-103 Ci 0.00E+00 __0.00E+00 6.42E-06 2.15E-04 Aq-110M Ci 0.00E+00 0.00E+00 1.54E-05 0.03E+00 I-131 Ci 0.00C+00 0.00E+00 2.56E-03 9.59E-04 I-132 Ci 0.00E+00 0.00E+00 6.16E-06 0.00E+00 I-133 Ci 0.00E+00 0.00E+00 3.85E-03 5.09E-04 4
Page 2 of 16
Year 1986 LIQUID EFFLUENTS
/
Continuous Mode Batch Mode NUCLIDES Quarter Quarter Quarter Quarter RELEASED Unit 1 2 1 2 I-135 Ci 0.00E+00 0.00E+00 4.54E-04 6.41E-05 Cs-137 Ci 0.03E+00 0.00E+00 1.49E-05 1.56E-03 Ba-140 Ci 0.00E+00 0.00E+00 2.24E-04 7.92E-05 La-140 Ci 0.00E+00 0.00E+00 3.35E-03 2.55E-03 l
Ce-144 Ci 0.00E+00 0.0DE+00 3.19E-03 1.05E-02 W-187 Ci E.00E+00 0.00E+00 4.31E-03 6.96E-04 Kr-85 Ci 0.0EE+00 0.00E+00 1.20E-01 7.95E-01 Kr-88 Ci 0.00E+00 0.00E+00 1.79E-05 0.00E+00 Xe-13DH Ci 0.00E+00 0.03E+00 3.47E-04 3.16E-02 Xe-133M Ci 0.00E+00 0.00E+00 2.28E-04 1.86E-03 Xe-133 Ci 0.03E+00 0.03F+00 2.83E-02 8.09E-03 Xe-135M Ci 0.00E+00 0.00E+00 3.25E-03 2.55E-02 Xe-135 Ci 0.03E+00 0.03E+00 1.65E-02 3.53E-03 Ar-41 Ci 0.00E+00 0.00E+00 1.40E-05 7.56E-06 Sn-ll7M Ci 0.00E+00 0.00E+00 9.39E-05 4.57E-04 Sn-ll3 Ci 0.00E+00 0.00E+00 2.76E-04 1.29E-03 Br-82 Ci 0.03E+00 0.00E+00 8.89E-05 0.03E+00 Be-7 Ci 0.00E+00 0.00E+00 1.43E-02 2.32E-03 Hf-181 Ci 0.0JE+00 0.03E+00 2.79E-05 1.25E-03 Page 3 of 16
Year 1986 LIQUID EFFLUEITfS 4
Continuous Mode Batch Mode NUCLIDES Quarter Quarter l Quarter Quarter PILEASED Unit 1 2 } 1 2 Sc-46 Ci 0.00E+00 0.00E+00 1.51E-05 4.72E-04 02-57 Ci 0.00E+00 0.00E+00 8.90E-06 1.92E-03 Nb-97 Ci 0.00E+00 0.00E+00 2.22E-05 4.26E-04 Sr-89 Ci 0.00E+00 0.00E+00 1.46E-05 <l.99E-04 Sr-90 Ci 0.00E+00 0.00E+00 2.48E-05 <l.99E-04 I-J24 Ci 0.00E+00 0.00E+00 0.00E+00 9.36E-06 Cs-130 Ci 0.00E+00 0.00E+00 <l.83E-03 1.01E-03 Ce-141 Ci 0.00E+00 0.00E+00 <1.83E-03 1.06E-03 Np-239 Ci 0.00E+00 0.00E+00 0.00E+00 4.95E-04 Ilf-175 Ci 0.00E+00 0.00E+00 0.00E+00 2.01E-05 Sb-124 Ci 0.00E+00 0.00E+00 0.00E+00 9.67E-04 Gross Alpha Ci 0.00E+00 0.00E+00 <3.65E-04 <3.97E-04 Fe-55 Ci 0.00E+00 0.00E+00 <3.65E-03 2.05E-02 h
4 Page 4 of 16-
r Year 1986 REPORT OF RADIOACTIVE EFFIUf2TfS: AIRBORNE Quarter Quarter Unit 1 2 A. Fission & Activation Gases
- 1. Total Release Ci 8.69E+00 1.52E+01
- 2. Average release rate for period uCi/sec 1.02E+01 5.05E+00
- 3. Percent of Technical Specification Limits % 1.73E-02 3.04E-02 B. Iodines
- 1. Total Iodine-131 Ci 8.40E-5 0.00E+00
- 2. Average release rate for period uCi/sec 1.08E-05 0.00E+00 3 Percent of Technical Specification Limits % 8.40E-03 0.00E+00 _
C. Particulates
- 1. Particulates with half-lives > 8 days Ci 0.00E+00 0.00E+00
- 2. Average release rate for period uCi/sec 0.00E+00 0.00E+00
- 3. Percent of Technical Specification Limits 0.00E+00
% 0.00E+00
- 4. Gross Alpha radioactivity Ci 0.00E+00 0.00E+00 D. Tritium
- 1. Total Release Ci 3.56E+00 1.59E+01
- 2. Average release rate for period uCi/sec 4.92E-01 2.22E+00
- 3. Percent of Technical Specification Limits % 2.37E-04 1.06E-03 6
l Page 5 of 16
Year 1986 GASEOUS EFFLUEtTfS Continuous Mode Batch Mode NUCLIDES Quarter Quarter Quarter Quarter PersASED Unit- 1 2 1 2
- 1. Fission and Activation Gases l
Ar-41 Ci 0.00E+00 0.00E+00 2.88E-01 1.98E-01 KR-85 Ci 0.00E+00 0.00E+00 0.00E+00 0.00E+00 KR-85m Ci 0.00E+00 0.00E+00 2.41E-04 8.75E-05 KR-87 Ci 0.00E+00 0.00E+00 0.00E+00 0.00E+00 KR-88 Ci 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Xe-131m Ci 0.00E+00 0.00E+00 4.16E-06 1.58E-03 Xe-133 Ci 6.52E+00 1.01E+01 8.59E-01 3.25E+00 Xe-133m Ci 0.00E+00 0.00E+00 8.96E-04 0.00E+00 Xe-135 Ci 9.94E-01 1.58E+00 3.24E-02 1.33E-01 Xe-135m Ci 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Xe-138 Ci 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Tbtal Ci 7.51E+00 1.16E+01 1.18E+00 3.58E+00
- 2. IIalogens (Gaseous)
I-131 Ci 8.40E-05 <2.86E-04 <l.85E-07 <l.83E-06 1-133 Ci <2.83E-02 <2.86E-02 <l.85E-05 <l.83E-04 I-135 Ci 0.00E+00 0.00E+00 0.00E+00 0.00E+00 Br-82 Ci 0.00E+00 0.00E+00 0.00E+00 0.00E+00
'Ibtal Ci 8.40E-05 0. 00E i-00 0.00E+00 0.00E+00 Page 6 of 16' m . . - _ _ _ _ - _ - . - - - _ - - - _ - . . _ . _ _ _ _ _ __- ,_ - -__ -- - -
1 Year 1986 GASEOUS EFFLUENTS Continuous Mode Batch Mcde NUCLIDES Quarter Quarter Quarter Quarter RELEASED Unit 1 2 1 2
- 3. Particulates Gross Alpha Ci <2.83E-03 <2.86E-03 <l.85E-06 <l.83E-05 Sr-89 Ci <2.83E-03 <2.86E-03 <l.85E-06 <l.83E-05 Sr-90 Ci <2.83E-03 '<2.86E-03 <l.85E-06 <l.83E-05 H-3 Ci 3.56E00 1.56E01 4.39E-03 2.30E-01 Mn-54 Ci <2.83E-03 <2.86E-03 <1.85E-06 <1.83E-05 Fe-59 Ci <2.83E-03 <2.86E-03 <l.85E-06 <l.83E-05 00-58 -Ci <2.83E-03 <2.86E-03 <l.85E-06 <l.83E-05 i
00-60 Ci <2.83E-03 <2.86E-03 <l.85E-06 <l.83E-05 Zn-65 Ci <2.83E-03 <2.86E-03 <1.85E-06 <l.83E-05
_ Mo-99 Ci <2.83E-33 <2.86E-03 <l.85E-06 <l.83E-05 Cs-134 Ci <2.83E-03 <2.86E-03 <l.85E-06 <l.83E-05 Cs-137 Ci <2.83E-03
<2.86E-03 <l.85E-06 <l.83E-05 Ce-141 Ci <2.83E-03 <2.86E-03 <l.85E-06 <l.83E-05 Ce-144 Ci <2.83E-03 <2.86E-03 <l.85E-06 <l.83E-05 Page 7 of 16 I _
SECTION II Supplemental Information ,
Facility: Wolf Creek Generating Station License Number: NPF-42 -
1.' Regulatory Limits 1
A. For liquid waste effluents A.1 % e concentration of radioactive material released in liquid effluents to UNRESTRICTED AREAS shall be limited to the concentrations specified in 10 CFR Part 20,1 Appendix B, Table II, Column 2, for radionuclides other than dissolved or entrained noble gases. For dissolved or engrained noble gases, the concentration
- . shall be~ limited to 2 x 10 - microcurie /ml total activity.
A.2 he dose or dose comitment to a MEMBER OF WE PUBLIC from
! radioactive materials in liquid effluents released, from each unit,
/- to UNRESTRICTED AREAS shall be' limited:
b a .- During any calendar quarter to less than or equal to 1.5 mrems to the whole body and to less than or equal to 5 mrems to any organ, and
- b. During any calendar year to less than or equal to 3 mrems to the whole body and to less than or equal to 10 mrems to any organ.
B. For gaseous. waste effluents 1.
- i .
B.1 %e dose rate due to-radioactive materials released in gaseous
- effluents frm che site to areas at and beyond the SITE BOUNDARY
.'l" shall be limited to the following:
- a. For noble gases: Less than or equal to 500 mrems/yr to the
, - whole body and less than or equal to 3000 mrems/yr to the skin, i
i and t b. For Iodine-131 and 133, for tritium, and for all radionuclides I in particulate form with half-lives greater than 8 days: Less than or equal to 1500 mrems/yr to any organ.
i B.2 The air dose due to noble gases released in gaseous effluents, from each unit, to areas at and beyond the SITE BOUNDARY shall be limited to the following:
- a. During any calendar quarter: Less than or equal to 5 mrads for
- gama radiation and less than or equal to 10 mrads for beta radiation, and
- b. During.any calendar year: Less than or equal to 10 mrads for
. gama radiation and less than or equal to 20 mrads for beta radiation.
L. +
Page 8 of 16
- 2. Maximum Permissible Concentrations Water - covered in section 1.A.
-Air - covered in section 1.B.
~3. Average energy of fission and activation gaseous effluents is not applicable.
4.- Measurements and Approximations of Total Radioactivity A. Liquid Effluents LIQUID RELEASE SAMPLING ME71EOD OF l TYPE OF ACTIVITY TYPE FREQUENCY ANALYSIS ANALYSIS
- 1. Batch Waste P.H.A. Principal Gamma Release P Entniters Tanks Each Batch P.H.A. I-131
- a. Waste Manitor P Dissolved and Tank One Batch /M P.H.A. I Entrained Gases (Gama Dnitters)
- b. Secondary Liquid P L.S. H-3 Each Batch Waste G.F.P. Gross Alpha Monitor Tank P O.S.L. Sr-89, Sr-90 Each Batch O.S.L. Fe-55 p = prior to each batch m = monthly P.H.A. = gama spectrum pulse height analysis using a High Purity Germanium detector. e L.S. = liquid scintillation G.F.P. = Gas Flow Proportional counting 0.S.L. = performed by an Offsite Laboratory There were no continuous radioactive waste effluents for this reporting period.
Page 9 of 16
B. Gaseous Waste Effluents SAMPLING METHOD OF TYPE OF GASEOUS, RELEASE TYPE FREQUENCY ANALYSIS ACTIVITY AIMLYSIS P
Each Tank P.H.A. Principal Gama Waste Gas Decay Tank Grab Sample Emitters P Principal Gama Containment Purge or Each PURGE P.H.A. Emitters Vent Grab Sample Gas Bubbler and L.S. H-3 (oxide)
Principal Gama Unit Vent M P.H.A. Emitters Grab Sample Gas Bubbler and L.S. H-3 (oxide)
Radwaste Building M P.H.A. Principal Gama Vent Grab Sample Emitters All Release Types as I-131 listed above Continuous P.H.A.
I-133 P.H.A.
Continuous Particulate Principal Gama Sample Emitters G.F.L.
Continuous Particulate Gross Alpha Composite Sample O.S.L.
Ccanposite Sr-89, Sr-90 Continuous Particulate Sample C. A conservative error of +30% has been estimated. This includes volumetric measurement device, flow measurement device and analytical errors.
- 5. Batch Releasus Were were fifty (50) gaseous batch releases during the report period.
The longest gaseous batch release took 216 hours0.0025 days <br />0.06 hours <br />3.571429e-4 weeks <br />8.2188e-5 months <br />, the shortest occurred over a twenty-seven (27) minute interval. % e average release took 6.5 hours5.787037e-5 days <br />0.00139 hours <br />8.267196e-6 weeks <br />1.9025e-6 months <br /> with a total gaseous batch release time of 327 hours0.00378 days <br />0.0908 hours <br />5.406746e-4 weeks <br />1.244235e-4 months <br />.
%ere were 402 liquid batch releases during the report period. We longest liquid batch release took 364 minutes while the shortest took only 31 minutes. %e average release time for the liquid batch releases was 60 minutes. Total release time for all 402 liquid batch releases was 402 hours0.00465 days <br />0.112 hours <br />6.646825e-4 weeks <br />1.52961e-4 months <br />.
Page 10 of 16
- ~ .,. , , -, -.m,w.v v - r
- 6. Abnormal Releases
'Ihere were no abnormal liquid or gaseous releases for this report period.
Page 11 of 16
SECTION III Additional Information s
- 1. Unplanned Releases h ere were no unplanned releases from the site of radioactive materials in gaseous or liquid effluents to unrestricted areas during the report period.
%ere were no changes to the Process Control Program (PCP) during this report period,
%e' ODCM was revised with Plant Safety Review Conmittee (PSBC) approval' on 6-03-86. %is was revision 2 to the ODCM. W e revised pages are dated 5-23-86. A new pathway, grass-goat-milk, was added to the dose calculations. In addition, there were scue changes made to the Environmental Sampling Program. Insert number one lists the specific changes and the revised pages of the ODCM are "tached following the description of the changes.
- 4. Major Changes to Liquid, Gaseous, or Solid Radwaste Systems These changes will be discussed in the next annual update of the Final Safety Analysis Report as allowed by Technical Specification 6.15.
- 5. Technical Specification Action Statement Information On January 22, 1986, at approximately 0715 CST, is was discovered that the daily channel check and quarterly analog channel operational test for the iodine and particulate monitoring skid sampler flow rate monitors for the Unit Vent System and Radwaste Building Vent System had been inadvertently excitried from the surveillance program. %erefore, these checks (tests) had not been performed since receipt of the facility operating license (March 11, 1985). Upon discovery of this situation, the Unit Vent and Radwaste Building Vent Systems were declared inoperable and the appropriate actions were implemented. We missing surveillances were completed at approximately 1414 CST on January 22, 1986, restoring the Unit Vent and Radwaste Building Vent System to operable status. This inoperability incident was reported in the Wolf Creek Generating Station Licensee Event Report (LER) number 86-003.
The Secondary Liquid Waste Monitor (HF-RE-45) was declared inoperable on 4-18-86 at 1730 CST due to excessive sight glass leakage. In order to repair the sight glass, a modification to the lines leading to and from the sight glass was required. The lines had to be cut and have unions welded.in place. %is required a plant modification request (PMR) be issued. By the time the PMR was adequately reviewed and approved for implementation 31 days had passed before the sight glass was repaired and monitor HF-RE-45 was declared operable. There were no further time limits for inoperability of liquid and gaseous monitoring instrumentation exceeded during this reporting period as listed in Technical Specifications 3.3.3.10 arxl 3.3.3.11.
Page 12'of 16
f.
%e quantity. of radioactive material contained in the liquid holdup tanks or gas storage tanks did not exceed the limits speified in Technical Specifications 3.11.1.4 or 3.11.2.6, respectively, during this report period.
- 6. Land Use Census here were no new locations for dose calculations identified during this -
report period.
- 7. Radioactive Shipments Were was one shipnent of solid radwaste material sent to Richland, Washington in this report period.
f i
2 a
l.
F f
Page 13 of 16
EFFIDENf ARE) WASTE DISPOSAL SEMIAINRL RE, POET (1986)
SOLID MASFE SHIPMENFS A. SOLID WASTE SIIIPPED OFFSITE WR BURIAL OR DISPOSAL (tbt irradiated fuel) l
- 1. Type of waste Unit 6-month Est. Total
, Period Error %
- a. Spent resins, filter sludges, m" 5.20E+00 evaporator bottans, etc. Ci 1.40E-01 2.50E+01
- b. Dry compressible waste, m' 5.90E+00 contaminated equip, etc. Ci, 4.80E-03 2.5PE+01
- c. Irradiated components, m" 0.00E+00 control rods, etc. Ci 0.00E+00 0.00E+00
- d. Other (describe) m' O.00E+00 Ci 0.00E+00 0.00E+00
- 2. Estimate of major nuclide composition (by type of waste)
- 3. Solid Waste Disposition Number of Shipments Mode of Transportation Destination 1 Truck Richland, Washington
- 4. Class of Solid Waste
- a. Class A -
- b. Clc,ss A
- 5. Type of Container
- a. LSA
- b. LSA
- 6. Solidification Agent
- a. Cement
- b. Not Applicable B. IRRADIATED FUEL SIIIPMENTS (Disposition)
There were no irradiated fuel shipments during this reporting period.
Page 14 of 16
Insert il StBSIARY OF OIANGES 'to THE GXM Page Change 11 Editorial change. Changed page number for Table 4-1 and 4-2.
iii Added Tables A.5-17 through A.5-20 to the listing of tables. Added page numbers to each figure in the list of figures.
4 Editorial change. Now using a lower case "u" for the micro (Mu) symbol.
7 Editorial change. Changed the formula Fd n = Fdt Fa to read Fd n = Fd/Fa.
-9 Same as change to page 4.
10 Same as change to page 4.
11 Same as change to page 4 20 Same as change to page 4.
21 Same as change to page 4.
23 Same as change to page 4.
24 Same as change to page 4. Also corrected Qi to be in uCi rather than Ci.
25 Same as change to page 4.
26 Same as change to page 4.
27 Added the calculation for the grass-goat-milk Pathway Factor. Also added the explanation of the terms for this calculation.
28 Same as change to page 4.
29 Same as change to page 4.
31 Editorial change. Corrected the first sentence of 3.4.1.3 to read ". . . with standard activities . ."
instead of ". . . with stand activities. ."
35 Added 3.e Rooted Aquatic Plants to the Environmental Monitoring Program. This pathway is a potentially sensitive indicator of nuclides released in liquid effluents.
4 Page 15 of 16
36 Locations B-8 and C-ll to Exposure Pathway / Sample 4.1, Milk, have been removed frm the program since residents at these locations no longer have milk animals.
Sample location Q-1 was removed due to the resident at Q-1 moving. Sample location G-1 was added as a replacement sample location.
37 Table 4.2 was revised to reflect the sampling location
, adjustments discussed above..
38 Editorial change. Added a page number to figure 4-1.
39 Editorial change. Added a page number to figure 4-2.
40 Map changed to reflect sampling location changes and add a page number to figure 4-3.
41 Editorial change. Added a page number to figure 4-4.
42 Editorial change of page nunber.
A-3 Same as change to page 4.
A-30 Added the Fm values for the grass goat-milk pathway.
A-44 Editorial change aligned the liver Cr-51 dose factor.
Ibte: Tables A.5-2 through A-5-1(i were repagenated, this changed the page number of these tables. Only the actual change to the table will be cmmented on.
A-45 through Editorial change. Added the word per between MEN /YR
, A-55 and uCi/m3 A-54 Table A.5-4 corrected the Strontium value from Sr-85 to Sr-89.
I
- A-62 Table A.5-8 editorial changes to Cr-51 bone, added a 0, and to Fe-55, realigned the E.
A-75 Table A.5-12 changed Ag-100m to read Ag-110m.
A-86 Added Tc-101 and its dose factor (2.04E04) to Table A.5-16.
s A-87 through These are new pages containing tables A.5-17 through A-98 A.5-20 which contain the RI factors for the grass-goat -
- r. ilk pathway.
1 Page 16 of 16
- LIST OF TABLES 4
Table Page
,r %
!y,) 4-1 Radiological Environmental Monitoring Program 36 -
4-2 Sampling Location Numbers, Distance (miles) and Directions 37 A.1-1 Bioaccumulation Factors to be Used in the Absence A-2 of Site Specific Data A.1-2 Dose Factors for Noble Gases and Daughters A-3 A.2-1 Inhalation Dose Factors for Adults A-4 A.2-2, Inhalation Dose Factors for Teenagers A-7 A.2-3 Inhalation Dose Factors for Child A-10 A.2-4 Inhalation Dose Factors for Infant A-13 A.2-5 External Dose Factor for Standing on A-16 Contaminated Ground A.3-1 Ingestion Dose Factor for Adults A-18
( A.3-2 Ingestion Dose Factor for Teenagers A-21 A.3-3 Ingestion Dose Factor for Child A-24 A.3-4 Ingestion' Dose Factor for Infant A-2.7 A.3-5 Stable Element Transfer Data A-30 A.4-1 Site Related Ingestion Dose Commitment for Adult A-31 A.4-2 Site Related Ingestion Dose Commitment Factor for A-34 Teenager A.4-3 Site Related Ingestion Dose Commitment Factor for A-37 Child '
A.4-4 Sito Related Ingestion Dose Commitment Factor for A-40 Infant A.5-1 Inhalation Dose Parameter for the Child A-43 A.5-2 Inhalation Pathway Factor for Adult (RI Factor) A-44 A.5-3 Inhalation Pathway Factor for Teenager (RI Factor) A-47 (j A.5-4 Inhalation Pathway Factor for Child (RI Factor) A-50 A.5-5 Inhalation Pathway Factor for Infant (RI Factor) A-53
-ii- 5-23-86
. _ . _ - _ . - - _ - - _ _ _ . _ _ _ _ , - ___, . . - . __ _ . -_ . 2 _
LIST OF TABLES Table y Pace h
- A.5-6 Grass-Cow-Milk Pathway Factor Adult (RI Factor) A-56 of Site Specific Data A.5-7 Grass-Cow-Milk Pathway Factor Teen (RI Factor) A-59 A.5-8 Grass-Cow-Milk Pathway Factor Child (RI Factor) A-62 A.5-9 Grass-Cow-Milk Pathway Factor Infant (RI Factor) A-65 A.5-10 Grass-Cow-Meat Pathway Factor Adult (RI Factor) A-68 A.5-11 Grass-Cow-Meat Pathway Factor Teen (RI Factor) A-71 A.5-12 Grass-Cow-Meat Pathway Factor Infant (RI Factor) A-74 A.5-13 Vegetation Pathway Factor Adult (RI Factor) A-77 A.5.-14 Vegetation Pathway Factor Teen (RI Factor) A-80 A.5-15 Vegetation Pathway Factor Child (RI Factor) A-83 A.5-16 Ground Plane Pathway Factor (RI Factor) A-86 A.5-17 Grass-Goat-Milk Pathway Factor Adult (RI Factor) A-87 A.5-18 Grass-Goat-MiAk Pathway Factor Teen (RI Factor) A-90 A.5-19 Grass-Goat-Milk Pathway Factor Child (RI Factor) A-93 A.5-20 Grass-Goat-Milk Pathway Factor Infant (RI Factor) A-96 LIST OF FIGURES 4.1 Atmospheric Sampling 38 4.2 Water Sampling Locations 39 4.3 Milk and vegetation Sampling Locations 40 4.4 Distant Sampling Location 41 B-1 Vertical Standard Deviation of Material in a Plume B-2 Plume Travel Distance Versus Fraction Remaining in Plume B-3 Plume Travel Distance Versus Relative Deposition Rate iii 05-23-86
s
/, g \ 2.1.1.1 STEAM GENERATOR BLOWDOWN DISCHARGE MONITOR
%/ SETPOINT (uCi/ml) = MPCI -131 X Fm+ FB '
FB where, MPC I -131 = Maximum Permissible Concentration of I-131, 3.0 E-7 uCi/ml.
Fm = Dilution flow rate.
FB = Blowdown flow rate.
The setpoint calculation is based on the minimum dilution flow rate, the maximum possible blowdown flow rate, and, due to changing conditions, I-131 which is the most restrictive isotope expected to be present.
On the event that an alarm is reached, the setpoint will be.
re-evaluated using the actual dilution flow rate, the actual blowdown flow rate, and the actual isotopic analysis as outlined limit of SpecificationThis evaluation willexceeded.
be used to ensure the in Section 2.1.2.
3.11.1.1 was not The setpoint will still be based on the MPC of I-131 due to the changing gem conditions of activity and I-131 being the most restrictive 5 i isotope.
V 2.1.1.2 TURBINE BUILDING DRAIN MONITOR Setpoint (uCi/ml) = MPCI -131 X m+ Fm FT where, MPC I -131 = 3.0 E-7 uCi/ml.
Fm = Dilution flow rate.
FT = Turbine Building drain flow rate.
The setpoint is based on the minimum ditution flow rate, the maximum possible Turbine Building drain flow rate, and the most restrictive isotope expected to be present, I-131.
On the event that an alarm is reached, the release will be evalu-ated to-see if the limit of Specification 3.ll.l.1'was exceeded by using the actual dilution flow rate, the actual Turbine Building drain flow rate, and the actual isotopic analysis as outlined in Section 2.1.2. The setpoint will still be based on the MPC of s I-131 due to the changing conditions of activity and I-131 being (ew
( ,) the most restrictive isotope.
ODCM 4 05-23-86 L
-. . . - . . - . . - . - - - - -- =_. . .-- - .- - - - - .
/3 U -
Fdn = Fd/Fa Where Fa is the allocation factor which will modify the required dilution factor so that simultaneous liquid releases may be made without exceeding 10CFR20 limits.
The most straight-forward determination of allocation factor is _
- Fa = 1/n Where
n =
The number of liquid discharge pathways for which Ed > 1 and which are planned for simultaneous release.
However, this value for Fa may be unnecessarily restrictive in that all relea'se pathways are apportioned the same fraction of the available dilution stream, regardless of the relative concentrations of each of the sources.
Since the radionuclide concentration of the two continuous sources is expected to be less than that of the batch release r~'s source, it is acceptable to allocate smaller portions of the
( ,) dilution stream to the continuous releases and a larger portion to the batch releases.
Therefore, Fa is defined as a flexible quantity with a default value of 1/n. Prior to initiating simultaneous release, a check will be made to assure that the sum of the allocation factors assigned to pathways for the simultaneous release is < 1.
- 4) The calculated maximum permissible waste tank effluent flow i
rate, Fmax, is based on the modified dilution factor, Fd n, and the effective dilution flow rate, Feff.
The cooling lake into which the effluent is discharged is also the source of the dilution stream. It is therefore necessary to take into account the recirculation of previously emitted radionuclides should they be detected by sample analysis of the cooling lake water. This is accomplished by defining an effective dilution flow rate as Feff = Fm [1 - di LCi ]
[ i MPCi )
t ODCM 7 05-23-86 L u
1
^
l
? (
Where: '
A =
Adjustment factor which will allow the setpoint to be
, established in a practical manner for convenience and to prevent spurious alarms.
4 f
- A=
1 If A > 1, Calculate c and determine the maximum value for the actual monitor setpoint (uci/ml).
If A < 1, No release may be made.
If Fd < 1, no further dilution is required and the release may be made without regard to available dilution or to other releases made simultaneously. However, it is necessary to establish a monitor setpoint which will provide alarm should r, the release concentration inadvertently exceed 10CFR20
('s )) limits. This can be accomplished by establishing the adjust-
- ment factor as follows
A = 1/Fd
{ 2.2 LIOUID EFFLUENT CONCENTRATION - COMPLIANCE WITH 10 CFR 20 Specification 3.11.1.1 requires that the radioactive material released in liquid effluents to unrestricted areas shall be limited to:
I
- a. The concentrations specified in 10 CFR Part 20, Appendix B, Table II, Column 2 for radionuclides c
, other than dissolved or entrained noble gases, l b. For dissolved or entrained noble gases, the concen-tration shall be limited to 2 x 10-4 uCi/ml total e activity.
, To chow compliance with this specification, concentrations of actual liquid effluents will be determined by performing an isotopic analysis. The liquid effluent monitors will provide
[ assurance that the liquid concentration limits are not exceeded.
ODCM 9 05-23-86
y 2.3 RADIOACTIVE LIOUID EFFLUENT DOSES - COMPLIANCE WITH 10 CFR 50, Appendix I Specification 3.11.1.2 requires that the dose to an individual from radioactive materials in liquid effluents released to unrestricted areas shall be limited to:
- a. During any calendar quarter to less than or equal to 1.5 mrem to the total body and to less than or equal to 5 mrem to any organ, and
- b. During any calendar year to less than or equal to 3 mrem to the total body and to less than or equal to 10 mrem to any organ.
To show compliance with this specification, cumulative dose contributions from actual liquid effluents will be determined using the following methodology:
m DT= '(AiT $b L=1 a t L CiL FL) where, h DT =
the cumulative dose commitment to the total body or any organ, T, from the liquid effluent for the total m
time period 1 AtL, in mrem.
L=1 tL = the length of the Lth time period ever which CiL and FL are averaged for all liquid releases, in hours.
Cin = the average concentration of radionuclide, 'i', in undiluted liquid effluent flow during time period t g, in uCi/ml FL = the near field average dilution factor for Cin during any liquid effluent release where:
f PL= (p) g Where:
f = Liquid Radioactive Waste Flow
(,
'\
\___/
ODCM 10 05-23-86 L -
I
\_) -
F = Discharge Structure Exit Flow, the sum of .
the release and dilution flow.
K = Applicable factor; the site dependent value for the mixing effect of the discharge structure.
This value is conservatively assumed to be 1 (one) for this section.
AiT = the site related ingestion dose commitment factor to the total body or any organ, 'T', for each identified '
principal gcama and beta emitter, mrem /hr per uCi/ml.
See Tables A.4-1 through A.4-4.
AiT = 1.14E5 (Uw/DW + UF .BFi) DFi where, DW
= Dilution factor from the near field area to the potable water intake for water consumption, for Wolf' Creek Generating Station this factor is 1 (one).
BFi -
= Bioaccumulation factor for radionuclide, 'i', in fish, pCi/Kg per pCi/1, from Table A.1-1 from
[)
\_/
Regulatory Cuide 1.109 (Rev. 1)
DFi = Dose Conversion factor for radionuclide, 'i',
in mrem /pCi, from Table A.3-1 through A.3-4 from Regulatory Guide 1.109 (Rev. 1) .
Uw = Water consumption, in kg/yr.
Up = Fish consumption, in kg/yr.
1.14E5 = units conversion factor = 106pci/uci X 10 ml/Kg 3 8760 hr/yr The dose calculations are based on the actual isotopic analysis of the radioactive liquid effluents, the radioactive liquid effluent flow, and the dilution flow.
ODCM 11 05-23-86
_ . _ _ . - - - . - - - - . - - - - - - -- -- - - - - - - -- - ---- - ----- *-~~~~- -
r p
' _- ) _
where:
Ki = Total body dose factor due to gamma emissions for each identified ~ noble gas radionuclide, in mrem /yr per uCi/m3, from Table A.1-2.
(X/0) = 2.2 E-06 sec/m3, The highest calculated annual average relative concentration at the restricted
, area boundary in the North Sector.
Qi = Release rate of radionuclide i from vent, in uCi/sec.
Li = Skin dose factor due to beta emissions for each identified noble gas radionuclide, in mrem /yr per uCi/m3, from Table A.1-2.
Mi = Air dose f actor due to gamma emissions for each identified noble gas radionuclide, in mrad /yr per uCi/m3 from Table A.1-2.
1.1 = Conversion constant of air dose to skin dose.
- b. Release rate limit for all radionuclides and radio-active materials in particulate form and radionuclides
, cther than noble gases:
I (P(i)IN i
(X/0) Oi) <l500 mrem /yr to any organ, where:
01 =
The release rate of radionuclides, i, in gaseous effluent from all vent releases, in uCi/sec.
P(i)IN = The dose parameter for radionuclides other than noble gases for the inhalation pathway, in mrem /yr per uCi/m3 See Table A.5-1.
(X/0) = 2.2 E-06 sec/m3 (the highest annual average) .
The highest calculated relative concentration for estimating the dose to an individual at the unrestricted area boundary in the N sector.
ODCM 20 05-23-86
O All radionuclides are assumed to be released in elemental
- form.
The specification is applicable to the location (unrestricted area boundary or beyond), characterized by the value of X/O which results in the maximum total body or skin dose commitment.
~
The factors Ki, Li, and Mi relate the radionuclide airborne concentrations to various dose rates assuming a semi-infinite cloud. These factors are taken from Table B-1 of the Regulatory Guide 1.109 and multiplied by 106 to convert pCi-1 to uCi-1 and listed in Table A.1-2.
The following equation for P(i)IN was taken from NUREG 0133:
P(i)IN (Inhalation) ;
P(i)IN = K' (BR) DFAi (mrem /yr per uCi/m3}
where:
K' = a constant of unit conversion, 106 pCi/uCi
= the breathing rate of the child age group
()
BR in m3/yr DFAi = the maximum organ inhalation dose factor for the child age group for the ith radionuclide, in mrem /pCi. The total body is considered as an organ in the selection of DFAl'.
The age group considered is the child group.
The child's breathing rate is taken as 3700 m3/yr from Table E-5 of Regulatory Guide 1.109. The inhalation dose factors for the child, DFAi are presented in Table E-9 of Regulatory Guide 1.109, in units of mrem /pci. .
Resolution of the units yields:
Pi (Inhalation) = 3.7 X 109 DFAi ODCM 21 05-23-86
where:- '
3.17 E-8 = The inverse of the number of seconds in a year.
Mi = The air dose factor due to gamma emissions for each identified noble gas radionuclide, in mrad /yr per uCi/m3 from Table A.1-2 (Reg. Guide 1.109, Table B-1, Col. 4)
Ni = The air dose factor due to beta emissions for -
each identified noble gas radionuclide, in mrad / year per uCi/m3 from Table A.1-2 (Reg.
Guide 1.109, Table B-1, Column 2) .
(X/Q) = 2.2 E-6 sec/m3 The highest calculated annual average relative ~ concentration for any area at the unrestricted area boundary.
'01 = The release of noble gas radlonuclides,
'i', in gaseous effluents, in uCi. Releases shall be cumulative over the calendar quarter or year as appropriate.
O i %I An average monthly air dose schedule should be setup to ensure section
- ' 3.11.2.2 of Wolf Creek Technical Specifications are not exceeded. The average monthly air dose should be as follows:
l a. For gamma radiation < l.6 mrad /mo.
j For beta radiation <~3.3 mrad /mo.
i ,
!' If the monthly average air dose for: (a) is exceeded, it should be noted that if the release is continued at the same (or higher) frequencies or activities the quarterly limit of Technical l Specification 3.11.2.2.A will be exceeded.
- b. For gamma radiation < 0.8 mrad /mo.
l r
For beta radiation f 1.6 mrad /mo.
3 If the monthly average air dose for: (b) is exceeded, it should be noted that if the release is continued at the same (or higher) frequencies-or activities the annual limit of Technical Specifica-l tion 3.11.2.2.B will be exceeded.
! If any of the above monthly average air doses are exceeded, l evaluation of the causes of the high air dose should be performed and stops should be taken to reduce the activity or frequency (e.g. delay the release of a Waste Gas Decay Tank) of the release.
LO 1
ODCM 23 05-23-86
{ . .
(A R;
)
3.3.2 RADIOIODINES, PARTICULATES, AND OTHER PADIONUCLIDES Specification 3.11.2.3-requires that the dose to an individual from iodine-131 and 133, tritium, and all radioactive materials in particulate form with half-lives greater than 8 days in gaseous effluents released to areas at and beyond the site boundary shall be limited to the following:
- a. During any calendar quarter to 1 7.5 mrem to any organ; and
- b. During any calendar year to i 15 mrem to any organ.
To show compliance with this specification, tha dose calculations for the actual releases of the subject materials are consistent with the methodology provided in Regulation Guide 1.109, Revision
- 1. The following dose calculations will be performed:
- a. D (mrem) = 3.17E-8 E i Ri (WQi)] 1 7.5 mrem
- b. S.
D (mrem) = 3.17E-8 i Ri (WQi)] i 15 mrem where:
3.17E-8 = The inverse of the number of seconds in a year.
01 = The release of radiciodines, radioactive materials in particulate form and radionuclides other than noble gases in gaseous effluents, 'i ' ,
in uCi. Releases shall be cumulative over the calendar quarter or year as appropriate. The 01 value shall be determined as the product of the flow rate through the release point and grab samples of the effluent analyzed in accordance with Radiological Effluent Technical Specifica-tion 3.11.2.1.
W = The annual average dispersion parameter for estimating the dose to an individual at the controlling location.
W= (X/0), 2.2 x 10-6 sec/m3 for the inhalation pathway.
W= (D/0), 1.8 E-8 m-2, for the food and ground plane pathways.
Ri = The dose factor for each identified radionuclide,
'i', in mrem /yr per uCi/m3 See Table A.5-2 through Table A.5-20.
ODCM 24 05-23-86
~
where:
Inhalation Pathway Factor, R [X/Q]
R [X/Q] = K '(BR) a(DFA i) a (mrem /yr per uCi/mh where:
K' = a constant of unit conversion, 106 pCi/uCi.
(BR)a = The breathing rate of the receptor of age group (a) , in m3/yr.
The breathing rates (BR:a for the various age groups are tabulated below, as given in Regulatory Guide 1.109, Table E-5.
AGE GROUP (a) BREATHING RATE (* /yr)
Infant 1400 Child 3700 Teen 8000 Adult 8000 (DFAi )a = The maximum organ inhalation dose factor for the receptor of age group (a) for the i th radionuclide, in mrem /pci.
The total body is considered as an organ in the selection of (DFAi)a. See Tables n.2-1, A.2-2, A.2-3, & A.2-4. From Regula-tory Guide 1.109, Tables E-7, E-8, E-9,.and E-10.
GroundPlanePathwayFactor,Rf[D/Q]
1 R (D/Q) = K 'K" (SF) DFG i [(1-e- it)//i](m2 mrem /yr per uCi/sec) where:
K' = A constant of unit conversion, 106 pCi/uci.
K" = A constant of unit conversion, 8760 hr/ year.
Ki = The decay constant for the i th radionuclide, sec-1 t = The exposure t une , 4.73 E8 sec (15 years).
f i )
v CDCM 25 05-23-86
DFGi = The ground plane dose convarsion factor for the ith radionuclide (mrem /hr per pCi/m2) , see Table A.2-5. (Regulatory Guide 1.109, Table E-6).
SF = The shielding factor (dimensionless), 0.7 (Reg.
Guide 1.109)
Grass-Cow-MilkPathwayFactor,Rh(D/Q]
1 OF (Dap)
R1 [D/Q] =K' /Yp) (e~if)
(Ai +2w ) Em (r) (DFLi) a (
(m2. mrem /yr per uCi/sec) where:
K' = A constant of unit conversion, 106 pCi/uCi.
Op = The cow's consumption rate, in Kg/ day (wet weight), 50 kg/ day. (Reg. Guide 1.109, Table E-3).
Uap = The receptor's milk consumption rate for age (a), in liters /yr. (Reg. Guide 1.109, Table 9 E-5)
Infant = 330 1/yr Child = 330 1/yr Teen = 400 1/yr.
Adult = 310 1/yr Yp = The agricultural productivity by unit area of pasture feed grass, in kg/m2, 0.7 kg/m2, (geg, Guide 1.109, Table E-15)
Fm = The stable element transfer coefficients, in days / liter, See Table A.3-5. (Reg. Guide 1.109, Table E-1) r = Fraction of deposited activity retained on cow's feed grass, r=1 for radiciodine and r= 0.2 for particulates. (Reg. Guide 1.109, Table E-15).
(DFLi)a = The maximum organ ingestion doce factor for the i th radionuclide for the receptor in age group 'a', in mrem /pCi. See Tables A.3-1, A.3-2, A.3-3, and A.3-4. (Reg. Guide 1.109, Table E-ll, E-12, E-13, and E-14) 9 ODCM 26 05-23-86
h di = The decay constant for the ith radionuclide, in sec -1 -
Aw = The decay constant for removal of activity on leaf and plant surfaces by weathering, 5.73 E-7 sec-1 (corresponding to a 14 day half-life) .
tf = The transport time from pasture to cow, to milk, to receptor, in sec, 1.73 E5 secs (2 days). (Reg. Guide 1.109, Table E-15) .
NOTE: The fraction of the year that the cow is on pasture and the fraction of the cow feed that is pasture grass is assumed to be 1.0, which is the most restrictive case.
Grass-Goat-Milk Pathway Factor, R (D/0]
RC[D/Q] =K' (9FIEapl}pm (r) (DFLi) a (1/Yp ) e - it )
t i
Ag+A, (m2 .
= mrem /yr per uCi/sec)
, where:
['T N- /
Og= The goat 's consumption rate, in Kg/ day (wet weight) ,
6 Kg/ day. (Reg. Guide 1.109, Table E-3).
t f = The trancpor'. time frOm pasture to goat, to milk, to receptor, in sar 1.73E5sec (2 days).
(Reg. Guide 1.109, Table E-15).
all other terms are defined under the Grass-Cow-Milk Pathway Factor.
I NOTE: The fraction of the year that the goat is on pasture and the fraction of the goat feed that is pasture grass is assumed to be 1.0, which is the most restrictive case.
The concentration of tritium in milk is based on the airborne concer.tration rather than the deposition. Thercfore, the RC is based on (X/0), i R [X/0) = K 'K" ' Fm0FU ap (DFLi) a [0.75 (0.5/H)]
(mrem /yr per aci/m3) where:
K" ' = a constant of unit conversion, 103 gm/Kg.
(Q
\) H = Absolute humidity of the atmosphere, 8 gm/m3, (Reg. Guide 1.109).
27 05-23-86
-n- ~e- , ,-w e--o,e--- , w qw-- -y, e,-,-.- --g-e,+e ,c,--e- -,-,-,,--y-w-e -w,mg- e , ~ -g- - , - - ,7,e,e-
~/'N 0.75 = The fraction oI total feed that is water. (NUREG
- 0133)
- \j ,
0.5 = The ratio of the specific activity of the feed grass water to the atmospheric water. (NUREG' 0133)
Grass-Cow-Meat Pathway Factor, R [D/Q]
1 M
Ri [D/Q) =K' (EFIEapl)Ff (r) (DFLi) a (1/Yp) e - itf di+1w (m2 . mrem /yr per uCi/sec) where: '
Ff = The stable element transfer coefficients, in dayc/kg, Table A.3-5. (Reg. Guide 1.109, Table E-1).
Uap = The receptor's meat consumption rate for age (a), in kg/yr. (Reg . Guide 1.109, Table E-5)
Infant = 0 Child = 41 Teen = 65 Adult Om = 110 tf = The transport time from pasture to receptor, in sec., 1.73 E6 (20 days) (Reg Guide 1.109, Table E-15).
The concentration of tritium in meat is based on its airborne concentration rather than the deposition. Therefore, the RM is based on (x/g): i R"[X/Q] = K 'K" ' Ff Of Uap (DFLi)a ( 0.75 ( 0. 5/H) ]
(mrem /yr per uCi/m3)
~
where:
All terms defined above.
Vegetation Pathway Factor, R (D/Q]
Man is considered to consume two types of vegetation (fresh and stored) that differs only in the time period between harvest and consumption, therefore:
D
[V 28 05-23-86
=
R [D/Q] =K' L
[ g ) ] (DFLi) a [(Uk) { fL) (e - it ) +(U$) (fg) (e Aith) j (m2 . mrem /yr per uCi/sec) '
where:
K' =
A constant of unit conversion, 106 pCi/uCi.
f Da =
The consumption rate of fresh leafy vegetation by the receptor in age group (a) ,
in kg/yr. (Reg Guide 1.109, Table E-5).
Infant = 0 kg/yr Child = 26 kg/yr Teen = 42 kg/yr
( Adult = 64 kg/yr 6
U = The consumption rate of stored a
vegetation by the receptor in age group (a),
Kg/yr. (Reg Guide 1.109, Table E-5) .
Infant = 0 kg/yr Child = 520 kg/yr Teen = 630 kg/yr Adult = 520 kg/yr.
/~m
(%)\ fL =
The fraction of the annual intake of fresh leafy vegetation grown locally. (def ault = 1.0)
(Reg. Guide 1.109)..
fg =
The fraction of the annual intake of stored vegetation grown locally. (default = 0.76)
tL =
The average time between harvest of leafy vegetation and its consumption, in seconds, 8.6 E4 sect (1 day). Reg . Guide 1.109) .
th = The average time between harvest of stored vegetation and its consumption, in seconds, 5.18 E6 secs (60 days) (Reg . Guide 1.109, Table E-15).
Yy =
The vegetation area density, 2.0 kg/m2 (Reg . Guide 1.109, Table E-15) .
All other f actors previously defined.
The concentration of tritium in vegetation is based on the air-borne concentration rather than the deposition. Therefore, the R{isbasedon (X/Q):
R [X/Q] = K' K"' [UkfL + U! fg] (DFLi) a [0.75 (0.5/li) ]
(mrem /yr por uCi/m3) 29 5-23-86
~s
( ) 3.4.1 PARTICULATE DETECTOR CALIBRATION
\J -
, 3.4.1.1 Beta particulate is monitored by a 50 mm diamter by 0.25 mm thick plastic scintillator optically coupled to a 50 mm diameter photomultiplier tube. This detector shall be calibrated over its range of energy and rate capabilities.
3.4.1.2 For energy ranga calibration four sources shall be used. Each source consists of a filter paper impregnated with a beta emitting radionuclide. The radionuclides used should be Tc-99, Cs-137, Cl-36, and Rh-106. Each source shall be positioned in the filter paper retaining ring and counted separately.
The count rates for each radionuclide source shall be recorded and the data plotted on a graph of cpm /uci versus average beta energy. This curve represents the detectors response characteristics over the range of beta energies observed. The efficiency for setpoint calculations shall be based on the efficiency of the detector for Cs-137, 3.4.1.3 The detector shall be calibrated for its rate capabilities using a filter paper impregnated with standard activities f"]
(,j of Cs-137. Increasing amounts of a standard Cs-137 solution shall be impregnated on a filter paper. The counts per minute for each Cs-137 standard shall be recorded and the data plotted on a graph of counts per minute versus activity. At least three sources covering approximately 1/4, 1/2, and 3/4 of full scale chall be checked.
3.4.2 IODINE DETECTOR CALIBRATION 3.4.2.1 Iodine gas is monitored by absorbing the gas on a charcoal filter element. The charcoal filter is viewed by an NaI(Tl) integral line gamma scintillator assembly.
i 3.4.2.2 Because of its short half life and the difficulty in handling gaseous iodine, barium sources shall be used for calibration. The photo peaks of interest are as follows:
A. Ba-133: 356 kev gamma is 0.69 efficient / disintegration
-s B. I-131: 364 kev gamma is 0.82 ef,ficient/ disintegration l n.)
ODCM 31 05-23-86 i
.. .- l -. . - . . --
O /
i b V i
- O j g TABLE 4.1 Sheet 2 of 3
, 3 RADIOLOGICAL ENVIRONMENTAL MONITORING PROGRAM i Number of Samples Exposure Pathway and Sampling and Type and Frequency and/or Sample Sample Locations Collection Frequency- of Analysis 4
i 3. WATERBORNE I .
j a. Surface One upstream location Monthly grab sample Monthly gamma isotopic 4
near the John Redmond analysis. Quarterly Reservoir spillway, one tribuim analysis of sample from Wolf Creek composite sample.
Cooling Lake discharge cove.
- b. Ground Three locations at Quarterly Quarterly gamma iso-l C-10, C-49, D-65, topic and trituim j u, one control location
- analysis.
l at B-12 (see Figure j 4-2).
I c. Drinking Municipal water Monthly composite
- Monthly gross beta and I
supplies at Burlington gamma isotopic analysis.
1 (upstream) and Le Roy Quarterly tritium analysis (downstream) (see Figure 4-2) . of composite sample.
1 d. Sediment from One sample from Semiannually Semiannual gamma iso-Shoreline Wolf Creek Cooling topic analysis.
Lake discharge cove.
i i
- e. Rooted Aquatic One Sample from Wolf Semiannually Semiannual gamma isotopic Plants Creek Cooling Lake analysis-i S discharge cove .
i i M
j LA
- i m
] 04
)
- Composite sampling shall be performed by collecting an aliquot at intervals not exceeding
] 2 hours2.314815e-5 days <br />5.555556e-4 hours <br />3.306878e-6 weeks <br />7.61e-7 months <br />. '
i 1
i [)
w
(, a) o
, g TABLE 4.1 4
= Sheet 3 of 3 RADIOLOGICAL ENVIRONMENTAL MONITORING PROGRAM Number of Samples j* Exposure Pathway and Sampling and and/or Sample Sample Locations Type and Frequency Collection Frequency of Analysis i
- 4. INGESTION Samples from P-2, Q-5, Semimonthly when j P-2, and a control Gamma isotopic and
- a. Milk sample from S-3 animals are on pasture; I-131 analysis of each i
' monthly at other times. sample.
(see Figure 4-3).
- b. Fish One sample from Wolf Semiannually Gamma isotopic analysis 1
Creek Cooling Lake, on edible portions 1
similar sample from John Redmond
- w Reservoir spillway as control
- c. Food Products Broad leaf vegetation samples locations R-1, Monthly during harvest. Gamma isotopic analysis on edible portions.
G-1 and A-1 on Figure
] 4-3; control at S-4 Two samples of crops At time of harvest Gamma isotopic analysis irrigated with Neosho on edible portions.
River water from loca-tions downstream of the Necsho-Wolf Creek Con-
{ fluence and one control j o sample upstream of the Con-
- m fluence ; (Locations will i
E vary from year to year).
w I
J a) 1 0%
4 .
- - _ _ . - _ = - . ~ . - . _ - . - . . . ._ .-
0 O O e
n 3
TABLE 4.2 SAMPLING LOCATION NUMBERS, DISTANCES (miles) AND DIRECTIONS i
l TLD and Air Particulate I* Location Distance / Location Distance / Location Distance / Location Distance Number Direction Number Direction Number Direction Number Direction
, 1 1.4/N 11 1.6/E 21 3.8/S 31 j 2 2.7/N 12 3.0/WNW 1.8/ESE 22 4.1/SSW 32 3.2/WNW 3 3.0/NNE 13 1.5/SE 23 4.5/SW 33 4 4.0/NNE 3.7/WNW 14 2.6/SE 24 4.1/WSW 34 4.0/NW 5 4.0/NE 15 4.5/ESE 25 3.6/W 35 6 4.4/ENE 16 4.2/E 4.6/NNW 26 2.6/WSW 36 4.2/N 7 1.9/NE 17 3.6/SE 2.7 2.1/SW 37 8 1.6/NNE 2.1/NNW 18 3.2/SSE 28 2.8/SW 38 1.2/NW 9 2.0/ENE 19 4.0/SSE 29 2.6/SSW l d 10 2.4/ENE 20 3.3/S 30 39 13.0/N 2.2/W 40 15.0/WNW Groundwater
- B-12 2.2/NE C-10 2.8/W C-49 2.9/SW D-65 3.9/S
! Milk and Food Products 1
l A-1 1.4/N F-1 1.6/ESE 0-1 1.3/NW S-3
!- 15.0/WNW 1
P-2 2.9/WNW 0-5 3.6/NW S-4 15.0/WNW 8,
e I$
i r
I
i s,
S 4 3 -
t . .
\ .
3
!/N N I. i.
\ >=. .~l. . = c.
f*
y'"
l x ;. , i <
.\
. b , --
, bps . . .
) .. ,.....:.. . .. . ..
/ /
(__. ./
- ? !. ,_ \i
/'S.
. s 4,x 's / / , l x
. v,, g. 4 +N ' '
7 .u. - -
..!... \, p[ . . :
--n.- l1 - ,i n
<,> a -
-L'_.-,> l' .
N.N
,,p. /
- -p - - . 4. '
,e l ;.
-,., . ,'y
- .\
_ s
. . , ;._ ! . . . . = . . . . _ . . .
) - e. .. s ..s, g.
.,'. (' _' . ......#
\
't'- ; .h ' ;
\ ,,.
"l .
'xi .
. ir'Ba,(.'4. j y 1./ .
. \ .
8.
"I4 ) i ,*+- 'h5 ; j' 's.: i ;% i .- \
. d O,....fi 9 .g
- /' f Ip"\
x sbi!.,f *.I J.*
-J.,.
l 5 [/ bl'M Q
. ' 1 4 _ , '.'.;. Ug '..
s<
' f j'
/ !#
,,'t I
b/:.n Mj\ri/.
'\ ,
\i H 'E~
i
,,:j . y p Jg-
.~.,s } .
' 5.
/',* :.
- s .. (
iQ q.,h$,i,&
..l' e,. z <. .w?',r-( i .S l
}
.a. .'! .s -
. i ,
<m.ins l .-
t3
\ . .
y s ,. . .
- pS
- r ,if / .uA-s* 1
. 1
'v'. ,L a.,s'N \ x . ;
4.1 ',I-..T
.1- \ ' ' ! '
-(1
- 's l~ '.1 . i
.,1. '\,' .s. ..i ].. *t
.m~
, s .. In . s\ ) > ;
-I
-~go: - i g ; .- ; , - ......
/
i s
m 3
/
J l ,,/ .,,'[
f, . .h l.
l
..,'.?,..
,v-s N
/ l' [ .
t...
/ :
.. ,'.'/;.
' /f '.' ..
i
/
t .
. k,Ap g.
.3 N
.s...-....g'.
\
s
/ N l_
a
. .$'s . :
- i. - . . .
.~ ,i w
- ) , f
-/,'
hj, p-
'c r' / m: s.:
I q.
\ ,
- vi !!
- . i.
J y 4 ,.;l ;m&. Di .,
c v ..,.
- t
/ , /. , , * * ~ f.- /l ..
I =~ .%*- ~ -+ [ J e' , :s .
w %o.. . :
- s, .% / . -/ y.. _
,,j
.g,
<v. .
g-*
A-. : /..~s
- ...,,q......1 - a, - - .- , .-
) r,[.
n ) l s . .,/
~ '..'-...a i \ ,l
\
J/
t .
n*
An \ s s
,..- n
- y, k/
+
y ...
--y------ e
, j' \,_ ;,
- l . ,,
\q/.
. w
. . g,('. . -.. / v .
l
' , ,_ . f; . t . * /. . .
b
>. Y U / 5
' ./ 1 ', .
U l s
l s.g '4 > 6 '* ,;
\ ,. L,
! .,,.. . .. ..} .b l i - P E .- A .
'j j l
~
- j. 90
.. j - --
\ p
- a-s ,
i l l t . !. .. . '
, },.
'.'l L L 'i a . .
.- .: :- .s FIGURE 4-1
( ~';
ATMOSPHERIC PATHWAY SAMPLING N / * -TLD
(-Particulate, Iodine, and TLD 38 05-23-86
w .
- - t 1 ,
s ,
_ . . . ,), 7 -
A . -
g..t.i
.g i . .
N- s g_
i x . . _ . _
,.d .
N.
,....4 . . ,. ..
rs / ..._. ! .
' /i4 ._ ___ / x;
/.
, ;.,, ._8 N. . ! !
, 6\ h ..
/
.. ,4, ' . .i )N,. , ,
- ,,} ...
_ :#. m/ !-
. i i /.' \ /'
u, .. s 1 : y .
.\
j . ,, #t T / !~.'NN s 9 4i z
'.N.._.lN.......N.Jf('>lJ. .
.i > r .b,t,. i <2./!
- . '\ .
r )
i
- : :d
"~
3 /
d '"I ' -
. . . . ' . ' . l. ./
- i: {
- l N pl !
~~l N ! i , \ f.3 A \ / L/._...</...L.. E'^ \i !
l &. h m!8t ,s:=f. Mi-/ i'?~ g;\-A - m. yAh
- ., m, .... .,
it
~.u. . .a a s h.,r.m .u r : .
u-
,p k ',r . - L ! M 7l 1- ! '
,Gt 5,e, e.d.-[ .-- i t., . ' '
j l 1 ..e. v. ' . .,; .i -- n s. .-i- _
e e....j
$. \ '
- 'T '
l}.M-f':in, r ,4 3/ :
_ _ e _. :,j : .a
..VMr a /* m l -
x
- n vv .,I-u s 7:i %. s >- .! : :
I,
\[ [
hE. h !
.g
.~ . - . .. . . ;\..
p .
,/ .
..,l Lh., ., A r'i
- \ , f.,,.u... j 'b .bl,h~l
/
pf4 D y'- -- - d
.y
/
- + I .bf'
).T..).
i :> t \ s
\l s
( _. l .,- l .,N
& :.$ ,j., j~ ; ~~ -y
.ru
) lf
/, ..
t..
/,- .,
jt, ,, ';
- l
- --- - -3,_ V
{\ , A r,l/...7---.\. -
\
. g, . ~ . x,I! . . . . y, \ .
. .j.
o/ Y ; \ '. ; ;*
c.-.., y .
. / .
L..
g
\
k ,<
3
/ ! /
) ..s.. .' ~,, , .; . ! [c' M \ ,r 3- - . . --.
}l._,.
1
...i . .
uus ';-
0 I i
% --.-e FIGURE 4-2 WATER AND SEDIMENT SAMPLING LOCATIONS
( 4 - SUHFACE WATER O - DRINKING WATER A - GROUND WATER
- A- SHORELINE SEDIMENT 39 05-23-86
= .
l
f
/ \ _
"[$ SHARPE w e v Ai - /
2 MILE NEW STHdWN,I n R- f i
\ '
b> , N 1\
gr P-2 ' T N
]j/ W[
L' N
/
f-
' 'J g WOLF CRE
~
3EllER ATING "T ATI N- '
i 4[" m
%W i
i / \ '* b s 1'^Q(6 %
v '
fr DUnt it/07 N' fA f n c r
\ >x ex
~
\
. /)
w wi \ W FIGURE 4-3 MILK f. VEGETATION SAMPLING LOCATIONS A - f1 ilk N - Broadleaf Vegetation 40 05-23-86
. l___ __ _
PIGURE 4-4 L-
.., , , . . , Dintant Sampling Loce.tionc
- g. ..u -
-a..m ;
em I
.., e.. . .;. . . . . . -; . ...-:.- u :. .
3 ; , . .
g j j
- , t-l . 5....
l l i ;
..g
! .i ;
,- ........;.. .....~
I h- ~ ~ 4 *
- k-
-.~:-----+-------.-...:-.-.h..."..
g . .
l I * .
' . . a. . . . . . l;. . . . . l.. . . . .:. . I ! ! : -F
/. . . ......... - ... N:- ....--... > a! .. *.....
. .<...........:.....v:.-
. . . . . .. s .- .-
'. . - . . . . . . .. .J_.. ... f .
......... ..... .....:... . . . . . . . . . . . . . . /. . . . .:. . . . .; - - .~ . A .-l
- .h I
..t.,,.,...,......-..;.....:.........;..-.....!....g.....:.... J 1
1
.............$~...-....-.!--_.*.....:.
~
4.......,.. . . . .
. .>..... ..- ......... - -.~...
,, f,,
I 3
t / --:2-.----*---.:--- -
%.. . - - - i - - - --:-- - . H ' - - - -;-
.g . .. .: -' I
- 4. , e
.,: p --
. i . :
- h ~ -- , .i / . .
p.' -.g.-:---:.-
.....;..........-4.7 .....--.m-
.'.....s Es r) .r _ . .- .--- : .
..... s . 3. .J '
- t. - i x.
- .u . .:. : . . . . . . . . ., . .
.. ...... . . 1 .
.w. -. . .-w. .....~........ ..
. -.1~ .
. .u , r. . . ,
.~. . .
r..
. .o =..
l .
s
\;
re
.v l t
. . . . . . t.....-,..'..f..
. . ' . _....;.i,......,
s.
.. .. : , .. s
.i e . ! r 7 y . . .
.s .
I.. . . . ,. .
. , m..
._,s_.
b.
.,.......8 j
7, ,11 e,.. - ,
.(7. . . .. ,\, t, ;
- p. ..,...,.
,.... r.
- ' . i.t ;. .
. ....:..,. m ,,
.3
-s . . . .
v.
- s. . , .
c..........~........-..,
4.
m I -
s
. . 10. m : -- ..e --.
l 1
....;.........s....... .
. . . . . . . . , . . ~ . . . . .....y
..;.. ..,sc
. . ;g .q . . . ,
p . . .......;...........:....
3 i. 1
. . e
. m_ ..
t .. ._
.....^...._ - . . - . ..... .. ..
i .
1
, . ..;.......,........ 3__._ .
g .
15 mt. ; : ; *
.-.i,...... ..
- v , , , , ; s_ -
p
! l .
.....2....... .
l j.. _ ; q . % - .,---
..... .. ..c,.
q.
- _ _.. _g,._.
. * . ,p .. , .
p...+.........;.....
- p . . . i.___ .; ; p.. 3... s;-.
, , . , i
.f .- - - .
, N. s ,. ., . . _ _.;. y..
\
.,,..;.,......p.._
p ..,j.
- p. .. .,. ... .:. .r s
. . . . .t. . . . .: .; x .: .a........_
i
.a..
. . . m. .
.s s , ,..
s . -.
p .. .. . . ..:, x .,
. 4 . I. , . ... ,-
,.........a..........s ,
v....
. s, .t -
- ; 'w.. . . . . . .
' +
- 1. , Ya . ..L .. . . .y. ! ; ; : :
I s....,, ,, ,. ......
.......g........ A.....,-- a" ', .,- ~-<.-
.. , L _., . j- 1 I 9 :
'.n....
l l t } i '
- . . .,. . . . .;. .. ;. . ..;1 .: . , l \ ;
....,...__......-w, l- .: {
l
. ... ,f .. ....... ..__.
n ..
.I-........3.s..l--*. N ; ..
,/ sr.j }l 4
, t. >
4 .
. . . . .. ., . . . -6 i .
. . , . . , .s . o
) ..
,, ., f .j. . .;.,
....:.....,.....r....>, , . e
. . l j ;
N.., s..
'---~-..~ ~--...-.............:...*...............:._;...... , s. . .
,-..-. ~.
e TLD 4 Broadleaf Ve9etation (o) s_/
A Air Particulate
.a (Drinking Water 41 05-23-86
,/~N 5.0 40 CPR 190 DOSE EVALUATION This section demonstrates compliance with Surveillance Requirements 4.11.4.1 and 4.11.4.2 of the Wolf Creek Generating Station Technical Specifications. Specifically, the annual (calendar year) dose of dose commitment to any Member of the Public due to release of radioactivity and to radiation from uranium fuel cycle sources shall be limited to less than or equal to 25 mrems to the whole body or any organ, except the thyroid, which shall be limited to less than or equal to 75 mrems.
Dose evaluations to demonstrate compliance with Technical Specifica-tion 3.11.4 only need to be performed if the release of radioactive materials in liquid or gaseous effluents exceed twice the limits of Technical Specification 3.11.1.2a, 3.11.1.2b, 3.11.2.2a, 3.11.2.2b, 3.11.2.3a, or 3.ll.2.3b. Otherwise, no further evalua-tion is required.
For the evaluation of doses to an individual from liquid releases, the method described in Section 2.0 will be used. For the evalua-tion of doses to an individual from gaseous releases, the methods described in Section 3.0 will be used.
Cumulative dose contributions from direct radiation from the reactor unit and from radwaste storage tanks shall be determined utilizing the results of routine plant perimeter surveys, TLD data
[) or a combination of both, when necessary.
V
)
42 05-23-86 I * .
i
.J TABLE A.1-2 OCSE FACIORS EUR IIBIE GASES AND DAUCirrERS*
Etal Body Gamma Air Beta Air Dose Factor Skin Dose Factor Dose Factor DJse Factor Ki Li Radionuclide (mrem /yr per uCi/m31 Mi Ni
, (mren/yr per uCi/m3) (mrad /yr per uCi/m3) (mrad /yr per uCi/m31 Fr-83m 7.56E-02**
1.93E+01 2.88E+02 Kr-85n 1.17E+03 1.46E+03 1.23E+03 1.97E+03 Kr-85 1.61E+01 '
1.34E+03 1.72E+01 1.95E+03 Kr-87 5.92E+03 9.73E+03 6.17E+03 1.03E+04 Fr-88 1.47E+04 2.37E+03 1.52E+04 2.93E+03 Kr-89 1.66E+04 1.01E+04 1.73E+04 1.06E+04 Kr-90 1.56E+04 7.29E+03 1.63E+04 7.83E+03 Xe-131m 9.15E+01 4.76E+02 1.56E+02 1.llE+03 Xe-133m 2.51E+02 9.94E+02 3.27E+02 1.48E+03 Xe-133 2.94E+02 3.06E+02 3.53E+02 1.05E+03 Xe-135m 3.12E+03 7.llE+02 3.36E+03 7.39E+02 Xe-135 1.81E+03 1.86E+03 1.92E+03 2.46E+03 Xe-137 1.42E+03 1.22E+04 1.51E+03 1.27E+04 o Xe-138 8.83E+03 4.13E+03 9.21E+03 4.75E+03
$ Ar-41 8.84E+03 2.69E+03 9.30E+03 3.28E+03 cn Based on Pegulatory G2ide 1.109 (Rev.1) .
- 7.56E-02 = 7.56 x 10 -2 1
y TABLE A.3-5*
STABLE ELEMENT TRANSFER DATA B iy F,( Cow) Fg Element Veg/ Soil Milk (d/1) Meat (d/kg)
H 4.8E 00 1.0E-02 + 1.2E-02 C 5.5E 00 1.2E-02 + 3.1E-02 Na 5.2E-02 4.0E-02 3.0E-02 P 1.1E 00 2.5E-02 + 4.6E-02 Cr 2.5E-04 2.2E-03 2.4E-03 Mn 2.9E-02 2.5E-04 8.0E-04 Fe 6.6E-04 1.2E-03 + 4.0E-02 Co 9.4E-03 1.0E-03 1.3E-02 Ni 1.9E-02 6.7E-03 5.3E-02 Cu 1.2E-01 1.4E-02 + 8.0E-03 Zn 4.0E-01 3.9E-02 3.0E-02 Rb 1.3E-01 3.0E-02 3.1E-02 Sr 1.7E-02 8.0E-04 + 6.0E-04 Y 2.6E-03 1.0E-05 4.6E-03 Zr 1.7E-04 5.0E-06 3.4E-02 Nb 9.4E-03 2.5E-03 2.8E-01 Mo 1.2E-01 7.5E-03 8.0E-03 Tc 2.5E-01 2.5E-02 4.0E-01 Ru 5.0E-02 1.0E-06 4.0E-01 Rh 1.3E 01 1.0E-02 O Ag Te 1.5E-01 1.3E 00 5.0E-02 1.0E-03 1.5E-03 1.7E-02 7.7E-02 I 2.0E-02 ~ 6.0E-03 + 2.9E-03 Cs 1.0E-02 1.2E-02 + 4.0E-03 Da 5.0E-03 4.0E-04 3.2E-03 La 2.5E-03 5.0E-06 2.0E-04 Ce 2.5E-03 1.0E-04 1.2E-03 Pr 2.5E-03 5.0E-06 4.7E-03 Nd 2.4E-03 5.0E-06 W
3.3E-03 1.8E-02 5.0E-04 1.3E-03 Np 2.5E-03 5.0E-06 2.0E-04
+Fm (Coat) values for milk (d/1)
Element Milk (d/1) 11 1.7E-01 C 1.0E-01 P 2.5E-01 Fc 1.35E-04 Cu 1.3E-02 Sr 1.4E-02 I 6.0E-02 Cs 3.0E-01
- Taken from Regulatory Guide 1.109 (Rev. 1)
A-30 05-23-86
TABLE A.5-2 INHAIATION PATIMAY FAC'IOR MREM /YR per uCi/M3 l ADULT (RI FAC'IORS) -
NUCLIDE BONE LIVER T BODY THYROID J
KIDNEY LUhG GI-LLI H-3 0.00E 01 1.26E 03 1.26E 03 1.26E 03 1.26E 03 l 1.26E 03 1.26E 03 C-14 1.82E 04 3.41E 03 3.41E 03 3.41E 03 3.41E 03 3.41E 03 3.41E 03 Na-24 1.02E 04 1.02E 04 1.02E 04 1.02E 04 1.02E 04 i 1.02E 04 1.02E 04 i
P .12 1.32E 06 7.71E 04 5.01E 04 0.00E-01
' 0.00E-01 0.00E-01 8.64E 04 Cr-51 0.00E 01 0.00E 01 1.00E 02 5.95E 01 2.28E 01 1.44E 04
' 3.32E 03 Mn-54 0.00E 01 3.96E 04 6.30E 03 0.00E-01 9.84E 03 1.40E 06 7.74E 04 Mn-56 0.00C 01 1.24E 00 1.83E-01 0.00E-01 1.30E 00 9.44E 03 2.02E 04 Fe-55 2.46E 04 1.70E 04 3.94E 03 0.00E-01 0.00E-01 7.21E 04 6.03E 03 Fe-59 1.18E 04 2.78E 04 1.06E 04 0.00E-01 0.00E-01 1.02E 06 1.88E 05
^
C0-58 0.00E 01 1.58E 03 2.07E 03 0.00E-01 0.00E-01 9.28E 05 1.06E 05 Co-60 0.00E 01 1.15E 04 1.48E 04 0.00E-01 0.00E-01 5.97E 06 2.85E 05 Ni-63 4.32E 05 3.14E 04 1.45E 04 G.00E-01 0.00E-01 1.78E 05 1.34E 04 Ni-65 1.54E 00 2.10E-01 9.12E-02 0.00E-01 0.00E-01 5.60E 03 1.23E 04 i Cu-64 0.00E 01 1.46E 00 6.15F-01 0.00E-01 4.62E 00 6.78E 03 4.90E 04 Zn-65 3.24E 04 1.03E 05 4.66E 04 0.00E-01 6.90E 04 8.64E 05 5.34E 04 i
2n-69 3.38E-02 6.51E-02 4.52E-03 0.00E-01 4.22E-02 9.20E 02 1.63E 01 Br-83 0.00E-01 0.00E-01 2.41E 02 0.00E-01 0.00E-01 0.00E-01 2.32E 02 i
Dr-84 0.00E-01 0.00E-01 3.13E 02 0.00E-01 0.00E-01 0.00E-01 1.64E-03 i
i
) Br-85 0.00E-01 0.00E-01 1.28E 01 0.00E-01 0.00E-01 0.00E-01 8.00E-15 Rb-86 0.00E-01 1.35E 05 5.90E 04 0.00E-01 0.00E-01 0.00E-01 1.66E 04
- Rb-88 0.00E-01 3.87E 02 1.93E 02 0.00E-01 0.00E-01 0.00E-01 3.34E-09 Rb-89 0.00E-01 2.56E 02 1.70E 02 0.00E-01 0.00E-01 0.00E-01 9.28E-12 2
Sr-89 3.04E 05 0.00E-01 8.72E 03 0.00E-01 0.00E-01 1.40E 06 3.50E 05 Sr-90 9.92E 07 0.00E-01 6.10E 06 0.00E-01 0.00E-01 9.60E 06 7.22E 05 Sr-91 6.19E 01 0.00E-01 2.50E 00 0.00E-01 0.00E-01 3.65E 04 1.91E 05 j Sr-92 6.74E 00 0.00E-01 2.91E-01 0.00E-01 0.00E-01 1.65E 04 4.30E 04
- Y-90 2.09E 03 0.00E-01 5.61E 01 0.00E-01 0.00E-01 1.70E 05 4
5.06E 05 Y-91M 2.61E-01 0.00E-01 1.02E-02 0.00E-01 0.00E-01 1.92C 03 1.33E 00
- Y-91 4.62E 05 0.00E-01 1.24E 04 0.00E-01 0.00E-01 1.70E 06 3.85E 05 i
Y-92 1.03E 01 0.00E-01 3.02E-01 0.00E-01 0.00E-01 1.57E 04 7.35E 04 i,
A-44 05-23-86 r
m---_m__- ,-~=,m-.
TABLE A.5-2 (Cont'd)
INHAIATION PA11MAY PACICR
/O. MREN/YR per uCi/M3 h ADULT (RI FACIORS) -
NUCLIDE BONE LIVER T BODY THYROID KIDNEY LUNG GI-LLI Y-93 9.44E 01 0.00E-01 2.61E 00 0.00E-01 0.00E-01 4.85E 04 2r-95 4.22E 05 1.07E 05 3.44E 04 2.33E 04 0.00E-01 5.42E 04 1.77E 06 1.50E 05 Zr-97 9.68E 01 1.96E 01 9.04E 00 0.00E-01 2.97E 01 7.87E 04 5.23E 05 Nb-95 1.41E 04 7.82E 03 4.21E 03 0.00E-01 7.74E 03 5.05E 05 1.04E 15 Mo-99 0.00E-01 1.21E 02 2.30E 01 0.00E-01 2.91E 02 9.12E 04 2.48E C5 Tc-99M 1.03E-03 2.91E-03 3.70E-02 0.00E-01 4.42E-02 7.64E 02 4.16E 03 Tc-101 4.18E-05 6.02E-05 5.90E-04 0.00E-01 1.08E-03 Ru-103 3.99E 02 1.09E-ll 1.53E 03 0.00E-01 6.58E 02 0.00E-01 5.83E 03 5.05E 05 1.10E 05 Ru-105 7.90E-01 0.00E-01 3.11E-01 0.00E-01 1.02E 00 1.10E 04 4.82E 04 Ru-106 6.91E 04 0.00E-01 8.72E 03 0.00E-01 1.34E 05 9.36E 06 9.12E 05 Ag-110M 1.08E 04 1.00E 04 5.94E 03 0.00E-01 1.97E 04 4.63E 06 3.02E 05 Te-125M 3.42E 03 1.58E 03 4.67E 02 1.05E 03 1.24E 04 3.14E 05 7.06E 04 Te-127M 1.26E 04 5.77E 03 1.57E 03 3.29E 03 4.58E 04 9.60E 05 1.50E 05 Tb-127 1.40E 00 6.42E-01 3.10E-01 1.06E 00 5.10E 00
['--- )/ Te-129M 9.76E 03 4.67E 03 1.58E 03 3.44E 03 3.66E 04 6.51E 03 1.16E 06 5.74E 04 3.83E 05 Te-129 4.98E-02 2.39E-02 1.24E-02 3.90E-02 1.87E-01 1.94E 03 3.57E 02 Te-131M 6.99E 01 4.36E 01 2.90E 01 5.50E 01 3.09R 02 1.46E 05 5.56E 05 Te-131 1.11E-02 5.95E-03 3.59E-03 9.36E-02 4.37E-02 1.39E 03 1.84E 01 Te-132 2.60E 02 2.15E 02 1.62E 02 1.90E 02 1.46E 03 2.88E 05 3.10E 05 I-130 4.58E 03 1.34E 04 5.28E 03 1.14E 06 2.09E 04 0.00E-01 7.69E 05 I-131 2.52E 04 3.58E 04 2.05E 04 1.19E 07 6.13E 04 0.00E-01 6.28E 03 I-132 1.16E 03 3.26E 03 1.16E 03 1.14E 05 5.18E 03 0.00E-01 4.06E 02 1-133 8.64E 03 1.48E 04 4.52E 03 2.15E 06 2.58E 04 0.00E-01 8.88E 03 I-134 6.44E 02 1.73E 03 6.15E 02 2.98E 04 2.75E 03 0.00E-01 1.01E 00 1-135 2.68E 03 6.98E 03 2.57E 03 4.48E 05 1.11E 04 0.00E-01 5.25E 03 Cc-134 3.73E 05 8.48E 05 7.28E 05 0.00E-01 2.87E 05 9.76E 04 1.04E 04 Cn-136 3.90E 04 1.468 05 1.10E 05 0.00E-01 0.56E 04 1.20E 04 1.17E 04 C3-137 4.78E 05 6.21E 05 4.28E 05 0.00E-01 2.22E 05 7.52E 04 8.40E 03
~~3 C3-138 3.31E 02 6.21E 02 3.24E 02 0.00E-01 4.80E 02 4.86E 01 1.85E-03
(\ ,) IM-139 9.36E-01 6.66E-04 2.74E-02 0.00E-01 6.22E-04 3.76E 03 8.96E 02 A-45 05-23-86
TABLE A.5-2 (Cont'd)
INHAIATION PAT!MAY FACTOR MRDyYR per uCi/M3 O ADULT (RI FACIORS) -
NUCLIDE BCNE LIVER T BODY 'DIYROID KIDNEY LUNG GI-LLI Ba-140 3.90E 04 4.90E 01 2.57E 03 0.00E-01 1.67L 01 1.27E 06 2.18E 05 Ba-141 1.00E-01 7.53E-05 3.36E-03 0.00E-01 7.00E-05 1.94E 03 1.16E-07 Ba-142 2.63E-02 2.70E-05 1.66E-03 0.00E-01 2.29E-05 1.19E 03 1.57E-16 La-140 3.44E 02 1.74E 02 4.58E 01 0.00E-01 0.00E-01 1.36E 05 4.$8E 05 to-142 6.83E-01 3.10E-01 7.72E-02 0.00E-01 0.00E-01 6.33E 03 2.11E 03 Ce-141 1.99E 04 1.35E 04 1.53E 03 0.00E-01 6.26E 03 3.62E 05 1.20E 05 Ce-143 1.86E 02 1.38E 02 1.53E 01 0.00E-01 6.08E 01 7.98E 04 2.26E 05 cc-144 3.43E 06 1.43E 06 1.84E 05 0.00E-01 8.48E 05 7.78E 06 8.16E 05 Pr-143 9.36E 03 3.75E 03 4.64E 02 0.00E-01 2.16E 03 2.81E 05 2.00E 05 Pr-144 3.10E-02 1.25E-02 1.53E-03 0.00E-01 7.05E-03 1.02E 03 2.15E-08 td-147 5.27E 03 6.10E 03 3.65E 02 0.00E-01 3.56E 03 2.21E 05 1.73E 05 W-187 8.48E 00 7.08E 00 2.48E 00 0.00E-01 0.00E-01 2.90E 04 1.55E 05 t;p-239 2.30E 02 2.26E 01 1.24E 01 0.00E-01 7.00E 01 3.76E 04 1.19E 05 O
A-46 05-23-86
TABLE A.5-3 INHAIATION PATHWAY FAC'IOR O MREM /YR per uCi/M3 TEEN (RI FAC'IORS) -
NUCLIDE BONE LIVER T BODY 'IHYROIE KIDNEY I13NG GI-LLI H-3 0.00E-01 1.27E 03 1.27E 03 1.27E 03 1.27E 03 1.27E 03 1.27E 03 0-14 2.60E 04 4.87E 03 4.87E 03 4.87E 03 4.87E 03 4.87E 03 4.87E 03 Na-24 1.38E 04 1.38E 04 1.38E 04 1.38E 04 1.38E 04 1.38E 04 1.38E 04 P-32 1.89E 06 1.10E 05 7.16E 04 0.00E-01 0.00E-01 0.00E-01 9.28E 04 Cr-51 0.00E-01 0.00E-01 1.35E 02 7.50E 01 3.07E 01 2.10E 04 3.00E 03 Mn-54 0.00E-01 5.11E 04 8.40E 03 0.00E-01 1.27E 04 1.98E 06 6.68E 04 Mn-56 0.00E-01 1.70E 00 2.52E-01 0.00E 01 1.79E 00 1.53E 04 5.74E 04 Fe-55 3.34E 04 2.38E 04 5.54E 03 0.00E 01 0.00E-01 1.24E 05 6.39E 03 Fe-59 1.59E 04 3.70E 04 1.43E 04 0.00E 01 0.00E-01 1.53E 06 1.78E 05 Cc-58 0.00E-01 2.07E 03 2.78E 03 0.00E 01 0.00E-01 1.34E 06 9.52E 04 Cbe60 0.00E-01 1.51E 04 1.98E 04 0.00E 01 0.00E-01 8.72E 06 2.59E 05 Ni-63 5.80E 05 4.34E 04 1.98E 04 0.00E 01 0.00E-01 3.07E 05 1.42E 04 Ni-65 2.18E 00 2.93E-01 1. 27 E-01 0.00E 01 0.00E-01 9.36E 03 3.67E 04 O Cu-64 Zn-65 0.00E-01 2.03E 00 3.86E 04 1.34E 05 8.48E-01 6.24E 04 0.00E 01 0.00E 01 6.41E 00 8.64E 04 1.11E 04 1.24E 06 6.14E 04 4.66E 04 2n-69 4.83E-02 9.20E-02 6.46E-03 0.00E 01 6.02E-02 1.50E 03 2.85E 02 Er-83 0.00E-01 0.00E-01 3.44E 02 0.00E 01 0.00E-01 0.00E-01 8.00E-15 Br-84 0.00E-01 0.00E-01 4.33E 02 0.00E 01 0.00E-01 0.00E-01 8.00E-15 Br-85 0.00E-01 0.00E-01 1.83E 01 0.00E-01 0.00E-01 0.00E-01 8.00E-15 Rb-86 0.00E-01 1.90E 05 8.40E 04 0.00E-01 0.00E-01 0.00E-01 1.77E 04 Rb-88 0.00E-01 5.46E 02 2.72E 02 0.00E-01 0.00E-01 0.00E-01 2.92E-05 Rb-89 0.00E-01 3.52E 02 2.33E 02 0.00E-01 0.00E-01 0.00E-01 3.38E-07 Sr-89 4.34E 05 0.00E-01 1.25E 04 0.00E-01 0.00E-01 2.42E 06 3.71E 05 Sr-90 1.08E 08 0.00E-01 6.68E 06 0.00E-01 0.00E-01 1.65E 07 7.65E 05 Sr-91 8.80E 01 0.00E-01 3.51E 00 0.00E-01 0.00E-01 6.07E 04 2.59E 05 Sr-92 9.52E 00 0.00E-01 4.06E-01 0.00E-01 0.00E-01 2.74E 04 1.19E 05 Y-90 2.98E 03 0.00E-01 8.00E 01 0.00E-01 0.00E-01 2.93E 05 5.59E 05 Y-91M 3.70E-01 0.00E-01 1.42E-02 0.00E-01 0.00E-01 3.20E 03 3.02C 01 Y-91 6.61E 05 0.00E-01 1.77E 04 0.00E-01 0.00E-01 2.94E 06 4.09E 05 Y-92 1.47E 01 0.00E-01 4.29E-01 0.00E-01 0.00E-01 2.68E 04 1.65E 05 A-47 05-23-86
TABLE A.5-3 (cont'd)
INilAIATION PATHWAY FACTOR MREM /YR per uCi/M3 O TEEN (RI FACIORS) -
NUCLIDE BONE LIVER T BODY THYROID KIENEY LUNG GI-ILI Y-93 1.35E 02 0.00E-01 3.72E 00 0.00E-01 0.00E-01 8.32E 04 5.79E 05 Zr 1.46E 05 4.58E 04 3.15E 04 0.00E-01 6.74E 04 2.69E 06 1.49E 05 Zr-97 1.38E 02 2.72E 01 1.26E 01 0.00E-01 4.12E 01 1.30E 05 6.30E 05 Nb-95 1.86E 04 1.03F 04 5.66E 03 0.00 E-01 1.00E 04 7.51E 05 9.6AE 04 Mo-99 0.00E-01 1.69E 02 3.22E 01 0.00E-01 4.11E 02 1.54E 05 2.69E 05 Tc-99M 1.38E-03 3.86E-03 4.99E-02 0.00E-01 5.76E-02 1.15E 03 6.13E 03 Tc-101 5.92E-05 8.40E-05 8.24E-04 0.00E-01 1.52E-03 6.67E 02 8.72E-07
, Ru-103 2.10E 03 0.00E-01 8.96E 02 0.00E-01 7.43E 03 7.83E 05 1.09E 05 Ru-105 1.12E 00 0.00E-01 4.34E-01 0.00E-01 1.41E 00 1.82E 04 9.04E 04 l
Ru-106 9.84E 04 0.00E-01 1.24E 04 0.00E-01 1.90E 05 1.61E 07 9.60E 05
- Ag-110M 1.38E 04 1.31E 04 7.99E 03 0.00E-01 2.50E 04 6.75E 06 2.73E 05 4 Tb-125M 4.88E 03 2.24E 03 6.74E 02 1.408 03 0.00E-01 5.36E 05 7.50E 04
! Te-127M 1.80E 04 8.16E 03 2.18E 03 4.38E 03 6.54E 04 1.66E 06 1.59E 05 1 Te-127 2.01E 00 9.12E-01 4.42E-01 1.42E 00 7.28E 00 1.12E 04 8.08E 01 1
Te-129M 1.39E 04 6.58E 03 2.25E 03 4.58E 03 5.198 04 1.98E 06 4.05E 05 '
Te-129 7.10E-02 3.38E-02 1.76E-02 5.18E-02 2.66E-01 3.30E 03 1.62E 03 1 Tb-131M 9.84E 01 6.01E 01 4.20E 01 7.25E 01 4.39E 02 2.38E 05 6.21E 05 l Tb-131 1.58E-02 8.32E-03 5.04E-03 1.24E-02 6.18 E-02 2.34E 03 1.51E 01 Te-132 3.60E 02 2.90E 02 2.19E 02 2.46E 02 1.95E 03 4.49E 05 4.63E 05 I-130 [
6.24E 03 1.79E 04 7.17E 03 1.49E 06 2.75E 04 0.00E-01 9.12E 03 i j I-131 3.54E 04 4.91E 04 2.64E 04 1.46E 07 8.40E 04 0.00E-01 6.49E 03 i
l I-132 1.59E 03 4.38E 03 1.58E 03 1.51E 05 6.92E 03 0.00E-01 1.27E 03
! I-133 1.22E 04 2.05E 04 6.22E 03 2.92E 06 3.59E 04 0.00E-01 1.03E 04 I-134 8.88E 02 2.32E 03 8.40E 02 3.95E 04 3.66E 03 0.00E-01 2.04E 01 i
! I-135 3.70E 03 9.44E 03 3.49E 03 6.21E 05 1.49E 04 0.00E-01 6.95E 03 i l Cc-134 5.02E 05 1.13E 06 5.498 05 0.00E-01 3.75E 05 1.46E 05 9.76E 03 j Cn-136 5.15E 04 1.94E 05 1.37E 05 0.00E-01 1.10E 05 1.78E 04 1.09E 04 1
Cc-137 6.70E 05 8.48E 05 3.11E 05 0.00E-01 3.04E 05 1.21E 05 8.488 03 i Cc-138 4.66E 02 8.56E 02 4.46E 02 0.00E-01 6.62E 02 7.87E 01 2.70E-01 l
IM-139 1.34E 00 9.44E-04 3.90E-02 0.00E-01 0.88E-04 6.46E 03 6.45E 03 i
J i
{ A-48 05-23-86
TABLE A.5-3 (Cont'd)
INHAIATICN PATHWAY FAC'ICR MREM /YR per uCi/M3 TEEN . (RI FACIORS) -
NUCLIDE BCNE LIVER T BC0Y TirIROID KIDNEY LUNG GI-LLI Ba-140 5.47E 04 6.70E 01 3.52E 03 0.00E-01 2.28E 01 2.03E 06 2.29E 05 Ba-141 1.42E-01 1.06E-04 4.74E-03 0.00E-01 9.84E-05 3.29E 03 7.46E-04 Ba-142 3.70E-02 3.70E-05 2.27E-03 0.00E-01 3.14E-05 1.91E 03 4.79E-10 La-140 4.79E 02 2.36E 02 6.26E 01 0.00E-01 0.00E-01 2.14E 05 4.87E 05 La-142 9.60E-01 4.25E-01 1.06E-01 0.00E-01 0.00E-01 1.02E 04 1.20E 04 Ce-141 2.84E 04 1.90E 04 2.17E 03 0.00E-01 8.88E 03 6.14E 05 1.26E 05 Ce-143 2.66E 02 1.94E 02 2.16E 01 0.00E-01 8.64E 01 1.30E 05 2.55E 05 Cc-144 4.89E 06 2.02E 06 2.62E 05 0.00E-01 1.21E 06 1.34E 07 8.64E 05 Pr-143 1.34E 04 5.31E 03 6.62E 02 0.00E-01 3.09E 03 4.83E 05 2.14E 05 Pr-144 4.30E-02 1.76E-02 2.18E-03 0.00E-01 1.01E-02 1.75E 03 2.35E-04 M3-147 7.86E 03 8.56E 03 5.13E 02 0.00E-01 5.02E 03 3.72E 05 1.82E 05 W-187 1.20E 01 9.76E 00 3.43E 00 0.00E-01 0.00E-01 4.74E 04 1.77E 05 NP-239 3.38E 02 3.198 01 1.77E 01 0.00E-01 1.00E 02 6.49E 04 1.32E 05 O
A-49 05-23-86
r TABLE A.5-4 INHALATION PA'IWAY FACIOR MREM /YR per uCi/M3 O OIILD (RI FACIORS) -
NUCLIEE BONE LIVER T BODY 'IHYROID KIDNEY LUNG GI-LLI 11-3 0.00E-01 1.12E 03 1.12C 03 1.12E 03 1.12E 03 1.12E 03 1.12E 03 C-14 3.59E 04 6.73E 03 6.73E 03 6.73E 03 6.73E 03 6.73E 03 6.73E 03 Na-24 1.61E 04 1.61E 04 1.61E 04 1.61E 04 1.61E 04 1.61E 04 1.61E 04 P-32 2.60E 06 1.14E 05 9.88E 04 0.00E-01 0.00E-01 0.00E-01 4.22E 04 Cr-51 0.00E-01 0.00E-01 1.54E 02 0.00E-01 2.43E 01 1.70E 04 1.08E 03 Mn-54 0.00E-01 4.29E 04 9.51E 03 0.00E-01 1.00E 04 1.58E 06 2.29E 04 Pn-56 0.00E-01 1.66E 00 3.12E-01 0.00E-01 1.67E 00 1.31E 04 1.23E 05 Fe-55 4.74E 04 2.52E 04 7.77E 03 0.00E-01 0.00E-01 1.11E 05 2.87E 03 Fe-59 2.07E 04 3.34E 04 1.67E 04 0.00E-01 0.00E-01 1.27E 06 7.07E 04 Co-58 0.00E-01 1.77E 03 3.16E 03 0.00E-01 0.00E-01 1.11E 06 3.44E 04 Co-60 0.00E-01 1.31E 04 2.26E 04 0.00E-01 0.0GE-01 7.07E 06 9.62E 04 Ni-63 8.21E 05 4.63E 04 2.80E 04 0.00E-01 0.00E-01 2.75E 05 6.33E 03 Ni-65 2.99E 00 2.96E-01 1.64E-01 0.00E-01 0.00E-01 8.18E 03 8.40E 04 0.00E-01 1.99E 00 1.07E 00 0.00E-01 6.038 00 9.58E 03 3.67E 04 OCu-64 Zn-65 4.26E 04 1.13E 05 7.03E 04 0.00E-01 7.14E 04 9.95E 05 1.63E 04 Zn-69 6.70E-02 9.66E-02 8.92E-03 0.00E-01 5.85E-02 1.42E 03 1.02E 04 Br-83 0.00E-01 0.00E-01 4.74E 02 0.00E-01 0.00E-01 0.00E-01 3.70E-15 Dt-84 0.00E-01 0.00E-01 5.488 02 0.00E-01 0.00E-01 0.00E-01 3.70E-15 Br-85 0.00E-01 0.00E-01 2.53E 01 0.00E-01 0.00E-01 0.00E-01 3.70E-15 Pb-86 0.00E-01 1.98E 05 1.14E 05 0.00E-01 0.00E-01 0.00E-01 7.99E 03 Rb-88 0.00E-01 5.628 02 3.66E 02 0.00E-01 0.00E-01 0.00E-01 1.72E 01 Rb-89 0.00E-01 3.45E 02 2.90E 02 0.00E-01 0.00E-01 0.00E-01 1.89E 00 Br-89 5.99E 05 0.00E-01 1.72E 04 0.00E-01 0.00E-01 2.16E 06 1.67E 05 Sr-90 1.01E 08 0.00E-01 6.44E 06 0.00E-01 0.00E-01 1.48E 07 3.43E 05 Sr-91 1.21E 02 0.00E-01 4.95E 00 0.00E-01 0.00E-01 5.338 04 1.74E 05 Br-92 1.31E 01 0.0uE-01 5.25E-01 0.00E-01 0.00E-01 2.408 04 2.42E 05 Y-90 4.11E 03 0.00E-01 1.11E 02 0.00E-01 0.00E-01 2.62E 05 2.68E 05 Y-91M 5.07E-01 0.00E-01 1.04E-02 0.00E-01 0.00E-01 2.81E 03 1.72E 03 Y-91 9.14E 05 0.00E-01 2.448 04 0.00E-01 0.00E-01 2.63E 06 1.048 05 OY-92 2.04E 01 0.00E-01 5.81E-01 0.00E-01 0.00E-01 2.39E 04 2.39E 05
. A-50 05-23-06
~ - - - -
7 TABLE A.5-4 (Cont'd)
INilAIATION PAT!!WAY FACIOR O MREM /YR per uCi/M3 OIILD (RI' FACTORS)
~
NUCLIDE BONE LIVER T BODY TilYPOID KIDNEY LUNG GI-LLI Y-93 1.86E 02 0.00E-01 5.11E 00 0.00E-01 0.00E-01 7.44E 04 3.89E 05 Zr-95 1.90E 05 4.18E 04 3.70E 04 0.00E-01 5.96E 04 2.23E 06 6.11E 04 Zr-97 1.88E 02 2.72E 01 1.60E 01 0.00E-01 3.88E 01 1.13E 05 3.511 05 Fb-95 2.35E 04 9.18E 03 6.55E 03 0.00E-01 8.62E 03 6.14E 05 3.70E 04 Mo-99~ 0.00E-01 1.72E 02 4.25E 01 0.00E-01 3.92E 02 1.35E 05 1.27E 05 Tc-99M 1.78E-03 3.48E-03 5.77E-02 0.00E-01 5.07E-02 9.51E 02 4.81E 03 Te-101 0.10E-05 8.51E-05 1.08E-03 0.00E-01 1.45C-03 5.85E 02 1.63E 01 Ru-103 2.79E 03 0.00E-01 1.07E 03 0.00E-01 7.03E 03 6.62E 05 4.48E 04 Ru-105 1.53E 00 0.00E-01 5.55E-01 0.00E-01 1.34E 00 1.59E 04 9.95E 04 Ru-106 1.36E 05 0.00E-01 1.69E 04 0.00E-01 1.84E 05 1.43E 07 4.29E 05 Ag-110M 1.69E 04 1.14E 04 9.14E 03 0.00E-01 2.12E 04 5.48E 06 1.00E 05 Tu-125M 6.73E 03 2.33E 03 9.14E 02 1.92E 03 0.00E-01 4.77E 05 3.38E 04 To-127M 2.49E 04 8.55E 03 3.02E 03 6.07E 03 6.36E 04 1.48E 06 O Tb-127 To-129M 2.77E 00 9.51E-01 1.92E 04 6.85E 03 6.10E-01 3.048 03 1.96E 00 6.33E 03 7.07E 00 5.03E 04 1.00E 04 1.76E 06 7.14E 04 5.62E 04 1.82E 05 Te-129 9.77E-02 3.50E-02 2.38E-02 7.14E-02 2.57E-01 2.93E 03 2.55E 04 Te-131M 1.34E 02 5.92E 01 5.07E 01 9.77E 01 4.00E 02 2.06E 05 3.08E 05 it-131 2.17E-02 8.44E-03 6.59E-03 1.70E-02 5.88E-02 2.05E 03 1.33E 03 Tb-132 4.81E 02 2.72E 02 2.63E 02 3.17E 02 1.77E 03 3.77E 05 1.38E 05 I-130 8.18E 03 1.64E 04 8.44E 03 1.85E 06 2.45E 04 0.00E-01 5.11E 03 I-131 4.81E 04 4.81E 04 2.73E 04 1.62E 07 7.88E 04 0.00E-01 2.84E 03 I-132 2.12C 03 4.07E 03 1.88E 03 1.94E 05 6.25E 03 0.00E-01 3.208 03 I-133 1.66E 04 2.03E 04 7.70E 03 3.85E 06 3.38E 04 0.00E-01 5.48E 03 1-134 1.17E 03 2.16E 03 9.95E 02 5.07E 04 3.30E 03 0.00E-01 9.55E 02 I-135 4.92E 03 8.73E 03 4.14E 03 7.92E 05 1.348 04 0.00E-01 4.44E 03 Cn-134 6.51E 05 1.01E 06 2.25E 05 0.00E-01 3.30E 05 1.21E 05 3.85E 03 Cn-136 6.51E 04 1.71E 05 1.16E 05 0.00E-01 9.55E 04 1.45E 04 4.18E 03 Co-137 9.07E 05 0.25E 05 1.28E 05 0.00E-01 2.82C 05 1.04E 05 3.628 03 O Cc-138 Da-139 6.33E 02 8.40E 02 1.84E 00 9.84E-04 5.55E 02 5.36E-02 0.00E-01 0.00E-01 6.228 02 8.62E-04 6.81E 01 5.77E 03 2.70E 02 5.77E 04 A-51 05-23-86
v TABLE A.5-4 (cont'd) ,
INHAIATION PNIMAY FACIOR MRfWYR per uCi/M3 OIIID (RI FACIORS) -
NUCLIDE BCNE LIVER T BODY 'IHYROID KIIEEY LUNG GI-LLI Ba-140 7.40E 04 6.48E 01 4.33E 03 0.00E-01 2.11E 01 1.74E 06 1.02E 05 Ba-141 1.96E-01 1.09E-04 6.36E-03 0.00E-01 9.47E-05 2.92E 03 2.75E 02 Ba-142 4.99E-02 3.60E-05 2.79E-03 0.00E-01 2.91E-05 1.64E 03 2.74E 00 La-140 6.44E 02 2.25E 02 7.55E 01 0.00E-01 0.00E-01 1.83E 05 2.26E 05 Ia-142 1.29E 00 4.11E-01 1.29E-01 0.00E-01 0.00E-01 8.70E 03 7.59E 04 Ce-141 3.92E 04 1.95E 04 2.90E 03 0.00E-01 8.55E 03 5.44E 05 5.66E 04 cc-143 3.66E 02 1.99E 02 2.87E 01 0.00E-01 8.36E 01 1.15E 05 1.27E 05 Ce-144 6.77E 06 2.12E 06 3.61E 05 0.00E-01 1.17E 06 1.20E 07 3.89E 05 Pr-143 1.85E 04 5.55E 03 9.14E 02 0.00E-01 3.00E 03 4.33E 05 9.73E 04 Pr-144 5.96E-02 1.85E-02 3.00E-03 0.00E-01 9.77E-03 1.57E 03 1.97E 02 tAl-147 1.08E 04 8.73E 03 6.81E 02 0.00E-01 4.81E 03 3.28E 05 8.21E 04 W-187 1.63E 01 9.66E 00 4.33E 00 0.00E-01 0.00E-01 4.11E 04 9.10E 04 NP-239 4.66E 02 3.34E 01 2.35E 01 0.00E-01 9.73E 01 5.81E 04 6.40E 04 O
O A-52 05-23-86
TADLE A.5-5 INilAIATICN PAT!!WAY FAC'IOR (7 MREM /YR per uCi/M3 h INFANT (RI FAC'IORS) -
NUCLIDE BONE LIVER T BODY TIIYROID XIDNEY IUNG GI-LLI
!!-3 0.00E-01 6.47E 02 6.47E 02 6.47E 02 6.47E 02 6.47E 02 6.47E 02 C-14 2.65E 04 5.31E 03 5.31E 03 5.31E 03 5.31E 03 5.31E 03 5.31E 03 Na-24 1.06E 04 1.06E 04 1.06E 04 1.06E 04 1.06E 04 1.06E 04 1.06E 04 P-32 2.03E 06 1.12E 05 7.74E 04 0.00E-01 0.00E-01 0.00E-01 1.61E 04 Cr-51 0.00E-01 0.00E-01 8.95E 01 5.75E 01 1.32E 01 1.28E 04 3.57E 02 Mn-54 0.00E-01 2.53E 04 4.98E 03 0.00E-01 4.98E 03 1.00E 06 7.06E 03 Mn-56 0.00E-01 1.54E 00 2.21E-01 0.00E-01 1.10E 00 1.25E 04 7.17E 04 Fe-55 1.97E 04 1.17E 04 3.33E 03 0.00E-01 0.00E-01 8.69E 04 1.09E 03 Fe-59 1.36E 04 2.35E 04 9.48E 03 0.00E-01 0.00E-01 1.02E 06 2.48E 04 Cb-58 0.00E-01 1.22E 03 1.82E 03 0.00E-01 0.00E-01 7.77E 05 1.11E 04 00-60 0.00E-01 8.02E 03 1.18E 04 0.00E-01 0.00E-01 4.51E 06 3.19E 04 1
Ni-63 3.39E 05 2.04E 04 1.16E 04 0.00E-01 0.00E-01 2.09E 05 2.42E 03 Ni-65 2.39E 00 2.84E-01 1.23E-01 0.00E-01 0.00E-01 8.12E 03 5.01E 04 Ih
\- /
Cu-64 0.00E-01 1.88E 00 7.74E-01 0.00E-01 3.98E 00 9.30E 03 1.50E 04 Zn-65 1.93E 04 6.26E 04 3.11E 04 0.00E-01 3.25E 04 6.47E 05 5.14E 04 Zn-69 5.39E-02 9.67E-02 7.18E-03 0.00E-01 4.02E-02 1.47E 03 1.32E 04 13r-83 0.00E-01 0.00E-01 3.81E 02 0.00E-01 0.00E-01 0.00E-01 1.40E-15 Br-64 0.00E-01 0.00E-01 4.00E 02 0.00E-01 0.00E-01 0.00E-01 1.40E-15 Dr-85 0.00E-01 0.00E-01 2.04E 01 0.00E-01 0.00E-01 0.00E-01 1.40E-15
- Rb-86 0.00E-01 1.90E 05 0.82E 04 0.00E-01 0.00E-01 0.00E-01 3.04E 03 Rb-88 0.00E-01 5.57E 02 2.87E 02 0.00E-01 0.00E-01 0.00E-01 3.39E 02 Rb-89 0.00E-01 3.21E 02 2.06E 02 0.00E-01 0.00E-01 0.00E-01 6.82E 01 Sr-89 3.98E 05 0.00E-01 1.14E 04 0.00E-01 0.00E-01 2.03E 06 6.40E 04 Sr-90 4.09E 07 0.00E-01 2.59E 06 0.00E-01 0.00E-01 1.12E 07 1.31E 05 l
Sr-91 9.56E 01 0.00E-01 3.46E 00 0.00E-01 0.00E-01 5.26E 04 7.34E 04 Sr-92 1.05E 01 0.00E-01 3.91E-01 0.00E-01 0.00E-01 2.38E 04 1.40E 05 Y-90 3.29E 03 0.00E-01 8.82E 01 0.00E-01 0.00E-01 2.69E 05 1.04E 05 Y-91M 4.07E-01 0.00E-01 1.39E-02 0.00E-01 0.00E-01 2.79E 03 2.35E 03
()
Y-91 5.88E 05 0.00E-01 1.57E 04 0.00-E01 0.00E-01 2.45E 06 7.03E 04 ig Y-92 1.64E 01 0.00E-01 4.61E-01 0.00E-01 0.00E-01 2.45E 04 1.27E 05 A-53 05-23-86
7 TABLE A.5-5 (Cont'd)
INHALATICN PATHWAY FACTOR O MREM /YR per oCi/M3 INFANr (RI FAC'AORS)
NUCLIDE BONE LIVER T BODY THYPOID KIDNEY LLNG GI-LLI Y-93 1.50E 02 0.00E-01 4.07E 00 0.00E-01 0.00E-01 7.64E 04 1.67E 05 Zr-95 1.15E 05 2.79E 04 2.03E 04 0.00E-01 3.11E 04 1.75E 06 2.17E 04 2r-97 1.50E 02 2.56E 01 1.17E 01 0.00E-01 2.59E 01 1.10E 05 1.40E 05 Nb-95 1.57E 04 6.43E 03 3.78E 03 0.00E-01 4.72E 03 4.79E 05 1.27E 04 Mo-99 0.00E-01 1.65E 02 3.23E 01 0.00E-01 2.65E 02 1.35E 05 4.87E 04 Tc-99M 1.40E-04 2.88E-03 3.72E-02 0.00E-01 3.11E-02 8.11E 02 2.03E 03 Tc-101 6.51E-05 8.23E-05 8.12E-04 0.00E-01 9.79E-04 5.84E 02 8.44E 02 Ru-103 2.02E 03 0.00E-01 6.79E 02 0.00E-01 4.24E 03 5.52E 05 1.61E 04 Ru-105 1.22E 00 0.00E-01 4.10E-01 0.00E-01 8.99E-01 1.57E 04 4.84E 04 Ru-106 8.68E 04 0.00E-01 1.092 04 0.00E-01 1.07E 05 1.16E 07 1.64E 05 Ag-110M 9.98E 03 7.22E 03 5.00E 03 0.00E-01 1.09E 04 3.67E 06 3.30E 04 Te-125M 4.76E 03 1.99E 03 6.58E 02 1.62E 03 0.00E-01 4.47E 05 1.29E 04 Te-127M 1.67E 04 6.90E 03 O Tb-127 Te-129M 2.23E 00 9.53E-01 1.41E 04 6.09E 03 2.07E 03 4.89E-01 2.23E 03 4.87E 03 1.85E 00 5.47E 03 3.75E 04 4.86E 00 3.18E 04 1.31E 06 1.03E 04 1.68E 06 2.73E 04 2.44E 04 6.90E 04 Tb-129 7.88E-02 3.47E-02 1.88E-02 6.75E-02 1.75E-01 3.00E 03 2.63E 04 Tu-131M 1.07E 02 5.50E 01 3.63E 01 8.93E 01 2.65E 02 1.99E 05 1.19E 05 Te-131 1.74E-02 8.22E-03 5.00E-03 1.58E-02 3.99E-02 2.06E 03 8.22E 03 Te-132 3.72E 02 2.37E 02 1.76E 02 2.79E 02 1.03E 03 3.40E 05 4.41E 04 I-130 6.36E 03 1.39E 04 5.57E 03 1.60E 06 1.53E 04 0.00E-01 1.99E 03 1-131 3.79E 04 4.44E 04 1.96E 04 1.48E 07 5.18E 04 0.00E-01 1.06E 03 1-132 1.69E 03 3.54E 03 1.26E 03 1.69E 05 3.95E 03 0.00E-01 1.90E 03 I-133 1.32E 04 1.928 04 5.60E 03 3.568 06 2.24E 04 0.00E-01 2.16E 03 1-134 9.21E 02 1.88E 03 6.65E 02 4.45E 04 2.09E 03 0.00E-01 1.29E 03 I-135 3.86E 03 7.60E 03 2.77E 03 6.96E 05 8.47E 03 0.00E-01 1.83E 03 Cc-134 3.96E 05 7.03E 05 7.45E 04 0.00E-01 1.90E 05 7.97E 04 1.33E 03 Cn-136 4.83E 04 1.35E 05 5.29E 04 0.00E-01 5.64E 04 1.18E 04 1.43E 03 Cn-137 5.49E 05 6.12E 05 4.55E 04 0.00E-0) 1.72E 05 7.13E 04 1.33E 03 Cc-138 5.05E 02 7.81E 02 3.98E 02 0.00E-01 4.10E 02 6.54E 01 8.76E 02 Ha-139 1.48E 00 9.84E-04 4.30E-02 0.00E-01 5.92E-04 5.95E 03 5.10E 04 A-54 05-23-86
TABLE A.5-5 (Cont'd)
INHAIATION PA'IEWAY FACIOR
/)
U' MREM /YR per uCi/M3 INFANT (RI FACTORS)
NUCLIDE ECNE LIVER T BODY THYPOID KIENEY LUNG GI-LLI Ba-140 5.60E 04 5.60E 01 2.90E 03 0.00E-01 1.34E 01 1.60E 06 3.84E 04 Ba-141 1.57E-01 1.08E-04 4.97E-03 0.00E-01 6.50E-05 2.97E 03 4.75E 03 Ba-142 3.98E-02 3.30E-05 1.96E-03 0.00E-01 1.90E-05 1.55E 03 6.93E 02 La-140 5.05E 02 2.00E 02 5.15E 01 0.00E-01 0.00E-01 1.68E 05 8.48E 04 La-142 1.03E 00 3.77E-01 9.04E-02 0.00E-01 0.00E-01 8.22E 03 5.95E 04 Ce-141 2.77E 04 1.67E 04 1.99E 03 0.00E-01 5.25E 03 5.17E 05 2.16E 04 Ce-143 2.93E 02 1.93E 02 2.21E 01 0.00E-01 5.64E 01 1.16E 05 4.97E 04 Ce-144 3.19E 06 1.21E 06 1.76E 05 0.00E-01 5.38E 05 9.84E 06 1.48E 05 Pr-143 1.40E 04 5.24E 03 6.99E 02 0.00E-01 1.97E 03 4.33E 05 3.72E 04 Pr-144 4.79E-02 1.85E-02 2.41E-03 0.00E-01 6.72E-03 1.61E 03 4.28E 03 bd-147 7.94E 03 8.13E 03 5.00E 02 0.00E-01 3.15E 03 3.22E 05 3.12E 04 W-187 1.30E 01 9.02E 00 3.12E 00 0.00E-01 0.00E-01 3.96E 05 3.568 04
,q NP-239 3.71E 02 3.32E 01 1.88E 01 0.00E-01 6.62E 01 5.95E 04 2.49E 04 L) o A-55 05-23-86
~
TABLE A.5-8 p)
(
GRASS-COW-MILK PA11MAY FACIOR M2 MREM /YR PER uCi/sec '
CHILD (RI FACTORS)
NUCLIDE BONE LIVER T BODY TilYROID KIDNEY LUNG GI-LLI 11 - 3 0.00E-01 1.57E 03 1.57E 03 1.57E 03 1.57E 03 1.57E 03 1.57E 03 C-14 1.19E 09 2.39E 08 2.39E 08 2.39E 08 2.39E 08 2.39E 08 2.39E 08 Na-24 8.86E 06 8.86E 06 8.86E 06 8.86E 06 8.86E 06 8.86E 06 8.86E 06 P-32 7.77E 10 3.64E 09 3.00E 09 0.00E-01 0.00E-01 0.00E-01 2.15E 09 Cr-51 0.00E-01 0.00E-01 1.02E 05 5.65E 04 1.54E 04 1.03E 05 5.40E 06 Mn-54 0.00E-01 2.10E 07 5.59E 06 0.00E-01 5.88E 06 0.00E-01 1.76E 07 Mn-56 0.00E-01 1.29E-02 2.90E-03 0.00E-01 1.56E-02 0.00E-01 1.86E 00 Fe-55 1.12E 08 5.93E 07 1.84E 07 0.00E-01 0.00E-01 3.35E 07 1.10E 07 Fe-59 1.20E 08 1.94E 08 9.69E 07 0.00E-01 0.00E-01 5.64E 07 2.02E 08 Co-58 0.00E-01 1.21E 07 3.71E 07 0.00E-01 0.00E-01 0.00E-01 7.07E 07 Co-60 0.00E-01 4.32E 07 1.27E 08 0.00E-01 0.00E-01 0.00E-01 2.39E 08 Ni-63 2.96E 10 1.59E 09 1.01E 09 0.00E-01 0.00E-01 0.00E-01 1.07E 08
/'~ Ni-65 2.078 00 1.95E-01 1.14E-01 0.00E-01 0.03E-01 0.00E-01 2.39E 01 (s )T Cu-64 0.00E-01 7.47E 04 4.51E 04 0.00E-01 1.81E 05 0.00E-01 3.51E 06 Zn-65 4.13E 09 1.10E 10 6.85E 09 0.00E-01 6.94E 09 0.00E-01 1.93E 09 2n-69 2.36E-11 3.42E-ll 3.16E-12 0.00E-01 2.07E-11 0.00E-01 2.15E-09 Pr-83 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 Br-84 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 Br-85 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 Rb-86 0.00E-01 8.77E 09 5.39E 09 0.00E-01 0.00E-01 0.00E-01 5.64E 08 Pb-88 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 Pb-89 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 Sr-89 6.62E 09 0.00E-01 1.89E 08 0.00E-01 0.00E-01 0.00E-01 2.56E 08 Sr-90 1.12E 11 0.00E-01 2.83E 10 0.00E-01 0.00E-01 0.00E-01 1.50E 09 Sr-91 1.29E 05 0.00E-01 4.88E 03 0.00E-01 0.00E-01 0.00E-01 2.85E 05 Sr-92 2.19E 00 0.00E-01 8.78E-02 0.00E-01 0.00E-01 0.00E-01 4.15E 01 Y-90 3.22E 02 0.00E-01 8.61E 00 0.00E-01 0.00E-01 0.00E-31 9.15E 05 Y-91M 2.70E-19 0.00E-01 9.82E-21 0.00E-01 0.00E-01 0.00E-01 5.29E-16
[)
Y-91 Y-92 3.90E 04 0.00E-01 2.54E-04 0.00E-01 1.04E 01 7.26E-06 0.00E-01 0.00E-01 0.00E-01 5.20E 06 0.00E-01 0.00E-01 0.00E-01 7.33E 00 A-62 05-23-86
TABLE A.5-12 (Cont'd)
GPASS-CON-MEAT PATWAY FACIOR M2 MPEM/YR PER uCi/sec CHILD (RI FACIORS)
NUCLIDE BONE LIVER T BODY THYPOID KIDNEY LUNG GI-LLI Y-93 1.04E-11 0.00E-01 2.87E-13 0.00E-01 0.00E-01 0.00E-01 1.56E-07 Zr-95 2.66E 06 5.86E 05 5.21E 05 0.00E-01 8.38E 05 0.00E-01 6.11E 08 Zr-97 3.22F-05 4.65E-06 2.74E-06 0.00E-01 6.68E-06 0.00E-01 7.05E-01 Nb-95 3.10E 06 1.21E 06 8.63E 05 0.00E-01 1.13E 06 0.00E-01 2.23E 09 Mo-99 0.00E-01 1.15E 05 2.84E 04 0.00E-01 2.45E 05 0.00E-01 9.51E 04 Tc-99M 6.27E-21 1.23E-20 2.04E-19 0.00E-01 1.79E-19 6.24E-21 7.00E-18 Tc-101 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 Ru-103 1.55E 08 0.00E-01 5.95E 07 0.00E-01 3.90E 08 0.00E-01 4.00E 09 Ru-105 9.16E-28 0.00E-01 3.32E-28 0.00E-01 8.05E-27 0.00E-01 5.98E-25
, Ru-106 4.44E 09 0.00E-01 5.54E 08 0.00E-01 5.99E 09 0.00E-01 6.90E 10 Ag-110M 8.34E 06 5.67E 06 4.53E 06 0.00E-01 1.06E 07 0.00E-01 6.74E 08 Te-125M 5.69E 08 1.54E 08 7.59E 07 1.60E 08 0.00E-01 0.00E-01 5.49E 08
(" Te-127M 1.77E 09 4.78E 08 2.11E 08 4.24E 08 5.06E 09 0.00E-01 1.44E 09
(_],/ Te-127 3.41E-10 9.20E-11 7.32E-ll 2.36E-10 9.71E-10 0.00E-01 1.33E-08 Te-129M 1.79E 09 5.00E 08 1.68E 08 5.77E 08 5.26E 09 0.00E-01 2.18E 09 Te-129 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 Te-131M 7.01E 02 2.43F 02 2.58E 02 4.99E 02 2.35E 03 0.00E-01 9.84E 03 Te-131M 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 Tb-132 2.12E 06 9.39E 05 1.13E 06 1.37E 06 8.72E 06 0.00E-01 9.46E 06 I-130 3.05E-06 6.17 E-06 3.18E-06 6.80E-04 9.22E-06 0.00E-01 2.89E-06 I-131 1.66E 07 1.67E 07 9.47E 06 5.51E 09 2.74E 07 0.00E-01 1.48E 06 I-132 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 I-133 5.70E-01 7.04E-01 2.66E-01 1.31E 02 1.17E 00 0.00E-01 2.84 E-01 I-134 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 I-135 6.59E-17 1.19E-16 5.61E-17 1.05E-14 1.82E-16 0.00E-01 9.04E-17 Cs-134 9.22E 08 1.51E 09 3.19E 08 0.00E-01 4.69E 08 1.68E 08 8.16E 06 Cs-136 1.59E 07 4.36E 07 2.82E 07 0.00E-01 2.32E 07 3.46E 06 1.53E 06 Cs-137 1.33E 09 1.28E 09 1.88E 08 0.00E-01 4.16E 08 1.50E 08 7.99E 06 Cs-138 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 Ba-139 0.00E-01 0.00E-01 0.00E-01 0.005-01 0.00E-01 0.00E-01 0.00E-01 A-75 05-23-86
t TABLE A.5-16 GROUND PLANE PATHWAY FACTOR
/"')
M2 MREM /YR PER uCi/sec
\m) (RI Factor) -
! H-3 0.00E 00 Y-91M 1.00E 05 Cs-134 C-14 6.86E 09 0.00E 00 Y-91 1.07E 07 Cs-136 1.49E 08 Na-24 1.19E 07 Y-92 1.80E 05 Cs-137 1.03E 10 P-32 0.00E 00 Y-93 1.85E 05 Cs-138 3.59E 05 Cr-51 4.66E 06 Zr-95 2.45E 08 Ba-139 1.06E 05 Mn-54 1.39E 09 'Zr-97 2.96E 06 Ba-140 2.05E 07 Mn-56 9.03E 05 Nb-95 1.37E 08 Ba-141 4.18E 04 Fe-55 0.00E 00 Mo-99 3.99E 06 Ba-142 4.49E 04 Fe-59 2.73E 08 Tc-99M 1.84E 05 La-140 1.92E 07 Tc-101 2.04E 04
- Co-58 3.79E 08 Ru-103 1.08E 08 La-142 7.37E 05 Co-60 2.15E 10 Ru-105 6.36E 05 Ce-141 1.37E 07 Ni-63 0.00E 00 Ru-106 4.21E 08 Ce-143 2.31E 06 Ni-65 3.02E 05 Ag-110M 3.44E 09 Ce-144 6.96E 07 Cu-64 6.07E 05 Te-125M 1.55E 06 Pr-143 0.00E 00 Zn-65 7.46E 08 Te-127M 9.17E 04 Pr-144 1.83E 0' Zn-69 0.00E 00 Te-127 2.98E 03 Nd-147 8.46E 06 Br-83 4.87E 03 Te-129M 1.98E 07 W-187 2.36E 06 Br-84 2.03E 05 Te-129 2.62E 04 Np-239 1.71E 06 Br-85 0.00E 00 Te-131M 8.03E 06 Rb-86 8.99E 06 Te-131 2.92E 04 Rb-88 3.31E 04 Te-132 4.23E 06 Rb-89 1.21E 05 5.51E 06 l O- Sr-89 2.16E 04 I-130 I-131 1.72E 07 Sr-90 0.00E 00 I-132 1.25E 06 ,
i Sr-91 2.14E 06 I-133 2.45E 06 Sr-92 7.77E 05 I-134 4.47E 05 l Y-90 4.49E 03 I-135 2.53E 06 i
j O
A-86 05-23-86
?
TABLE A.5-17 GRASS-GOAT-MILK PATWAY FACIOR
(]
(,-
M2 MREM /YR PER uCi/sec ADULT -
NUCLIDE BONE LIVER T BODY THYROID KIDNEY LUNG GI-LLI H-3 0.00E-01 1.56E 03 1.56E 03 1.56E 03 1.56E 03 1.56E 03 1.56E 03 C-14 2.63E 08 5.27E 07 5.27E 07 5.27E 07 5.27E 07 5.27E 07 5.27E 07 Na-24 2.93E 05 2.93E 05 2.93E 05 2.93E 05 2.93E 05 2.93E 05 2.93E 05 P-32 2.05E 10 1.27E 09 7.93E 00 0.00E-01 0.00E-01 0.00E-01 2.31E 09 Cr-51 0.00E-01 0.00E-01 3.43E 03 2.05E 03 7.55E 02 4.55E 03 8.62E 05 Mn-54 0.00E-01 1.01E 06 1.93E 05 0.00E-01 3.00E 05 0.00E-01 3.09E 06 Mn-56 0.00E-01 4.99E-04 8.85E-05 0.00E-01 6.34E-04 0.00E-01 1.59E-02 Fe-55 3.26E 05 2.25E 05 5.26E 04 0.00E-01 0.00E-01 1.26E 05 1.29E 05 Fe-59 3.86E 05 9.07E 05 3.48E 05 0.00E-01 0.00E-01 2.54E 05 3.02E 06 Cb-58 0.00E-01 5.66E 05 1.27E 06 0.00E-01 0.00E-01 0.00E-01 1.15E 07 00-60 0.00E-01 1.97E 06 4.34E 06 0.00E-01 0.00E-01 0.00E-01 3.70E 07 Ni-63 8.07E 08 5.65E 07 2.71E 07 0.]0E-01 0.00E-01 0.00E-01 1.17E 07
,, -ss Ni-65 5.56E-02 7.22E-03 3.30E-03 0.00E-01 0.00E-01 0.00E-01 1.83E-01 i ; Cu-64 0.00E-01 2.66E 03 1.25E 03 0.00E-01 6.70E 03 0.00E-01 2.27E 05
\~ '
Zn-65 1.65E 08 5.24E 08 2.37E 08 0.00E-01 3.50E 08 0.00E-01 3.30E 08 Zn-69 6.27E-13 1.20E-12 8.34E-14 0.00E-01 7.79E-13 0.00E-01 1.80E-13 Er-83 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 Br-84 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 Br-85 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 Rb-86 0.00E-01 3.11E 08 1.45E 08 0.00E-01 0.00E-01 0.00E-01 6.14E 07 Rb-88 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 Rb-89 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 Sr-89 3.05E 09 0.00E-01 8.75E 07 0.00E-01 0.00E-01 0.00E-01 4.89E 08 Sr-90 9.83E 10 0.00E-01 2.41E 10 0.00E-01 0.00E-01 0.00E-01 2.84E 09 Sr-91 6.02E 04 0.00E-01 2.43E 03 0.00E-01 0.00E-01 0.00E-01 Sr-92 2.87E 05 1.03E 00 0.00E-01 4.45E-02 0.00E-01 0.00E-01 0.00E-01 2.04E 01 Y-90 8.49E 00 0.00E-01 2.2SE-01 0.00E-01 0.00E-01 0.00E-01 9.00E 04 Y-91M 7.24E-21 0.00E-01 2.80E-22 0.00E-01 0.00E-01 0.00E-01 2.13E-20
(N Y-91 1.03E 03 0.00E-01 2.76E 01 0.00E-01 0.00E-01
( ,) Y-92 6.71E-06 0.00E-01 1.96E-07 0.00E-01 0.00E-01 0.00E-01 0.00E-01 5.67E 05 1.18E-01 A-87 05-23-86
~
y TABLE A.5-17 (Cont'd)
GRASS-GOAT-MILK P'A7WAY FACIOR M2 MREW YR PER uCi/sec
-y ADULT -
NUCLIDE BONE LIVER T BODY THYROID KIDNEY LUhG GI-LLI Y-93 2.80E-02 0.00E-01 7.73E-04 0.00E-01 0.00E-01 0.00E-01 8.87E 02 Zr-95 1.13E 02 3.63E 01 2.46E 01 0.00E-01 5.70E 01 0.00E-01 1.15E 05 Zr-97 5.20E-02 1.05E-02 4.80E-03 0.00E-01 1.58E-02 0.00E-01 3.25E 03 Nb-95 9.91E 03 5.51E 03 2.96E 03 0.00E-01 5.45E 03 0.00E-01 3.35E 07 Mo-99 0.00E-01 '2.97E 06 5.65E 05 0.00E-01 6.73E 06 0.00E-01 6.89E 06 Tc-99M 3.99E-01 1.13E 00 1.44E 01 0.00E-01 1.71E 01 5.53E-01 6.67E 02 Tc-101 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 Ru-103 1.22E 02 0.00E-01 5.26E 01 0.00E-01 4.66E 02 0.00E-01 1.43E 04 Ru-105 1.03E-04 0.00E-01 4.07E-05 0.00E-01 1.33E-03 0.00E-01 6.30E-02 Ru-106 2.45E 03 0.00E-01 3.10E 02 0.00E-01 4.73E 03 0.00E-01 1.58E 05 Ag-110M 6.99E 06 6.46E 06 3.84E 06 0.00E-01 1.27E 07 0.00E-01 2.64E 09 Te-125M 1.95E 06 7.08E 05 2.62E 05 5.88E 05 7.95E 06 0.00E-01 7.81E 06 Te-127M 5.49E 06 1.96E 06 6.70E 05 1.40E 06 2.23E 07 0.00E-01 1.84E 07 3
O Tb-127 Te-129M 7.84E 01 2.82E 01 7.22E 06 2.69E 06 1.70E 01 1.14E 06 5.81E 01 2.48E 06 3.19E 02 3.0 E 07 0.00E-01 0.00E-01 6.19E 03 3.64E 07 Tb-129 3.41E-11 1.28F-ll 8.31E-12 2.62E-ll 1.43E-10 0.00E-01 2.57E-ll Te-131M 4.33E 04 2.12E 04 1.77E 04 3.36E 04 2.15E 05 0.00E-01 2.10E 06 Te-131 4.40E-34 1.84E-34 1.39E-34 3.62E-34 1.93E--33 0.00E-01 6.23E-35 Te-132 2.88E 05 1.86E 05 1.75E 05 2.06E 05 1.80E 06 0.00E-01 8.82E 06 I-130 5.04E 05 1.49E 06 5.87E 05 1.26E 08 2.32E 06 0.00E-01 1.28E 06 I-131 3.558 08 5.08E 08 2.91E 08 1.67E 11 8.71E 08 0.00E-01 1.34E 08 I-132 1.98E-01 5.29E-01 1.85E-01 1.85E 01 8.43E-01 0.00E-01 9.94E-02 I-133 4.65E 06 8.08E 06 2.46E 06 1.19E 09 1.41E 07 0.00E-01 7.26E 06 I-134 2.44E-12 6.63E-12 2.37E-12 1.15E-10 1.05E-11 0.00E-01 5.78E-15 I-135 1.54E 04 4.04E 04 1.49E 04 2.66E 06 6.48E 04 0.00E-01 4.56E 04 Cs-134 1.70E 10 4.04E 10 3.30E 10 0.00E-01 1.31E 10 4.34E 09 7.06E 08 Cs-136 7.83E 08 3.09E 09 2.23E 09 0.00E-01 1.72E 09 2.36E 08 3.51E 08 i
Cs-137 2.21E 10 3.03E 10 1.98E 10 0.00E-01 1.03E 10 3.42E 09 5.86E 08 i
Cs-138 2.75E-23 5.43E-23 2.69E-23 0.00E-01 3.99E-23 3.94E-24 2.32E-28 Ea-139 5.48E-09 3.90E-12 1.60E-10 0.00E-01 3.65E-12 2. 21E-12 9.71E-09 i
i l A-88 05-23-86
7
'DWLE A.5-17 (Cont 'd)
GRASS-GOAT-MILK PA'DMAY FACIOR
[- M2 MRFM/YR PER uCi/sec '
ADULT NUCLIDE BONE LIVER T PODY THYROID- KIDNEY LUhD GI-LLI Ba-140 3.23E 06 4.05E 03 2.11E 05 0.00E-01 1.38E 03 2.32E 03 6.64E 06 Ba-141 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 Ba-142 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 La-140 5.43E-01 2.73E-01 7.23E-02 0.00E-01 0.00E-01 0.00E-01 2.01E 04 La-142 1.13E-12 5.12E-13 1.28E-13 0.00E-01 0.00E-01 0.00E-01 3.74E-09 Ce-141 5.81E 02 3.93E 02 4.46E 01 0.00E-01 1.83E 02 0.00E-01 1.50E 06 Ce-143 4.99E 00 3.69E 03 4.08E-01 0.00E-01 1.62E 00 0.00E-01 1.38E 05 Ce-144 4.29E 04 1.~i9E 04 2.30E 03 0.00E-01 1.06E 04 0.00E-01 1.45E 07 Pr-143 1.90E 01 7.60E 00 9.39E-01 0.00E-01 4.39E 00 0.00E-01 8.30E 04 Pr-144 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 Nd-147 1.14E 01 1.31E 01 7.85E-01 0.00E-01 7.67E 00 0.00E-01 6.30E 04 W-187 7.87E G7 6.58E 02 2.30E 02 0.00E-01 0.00E-01 0.00E-01 2.16E 05 Np-239 4.41E-01 4.33E-02 2.39E-02 0.00E-01 1.35E-01 0.00E-01 8.89E 03 o
a A-89 05-23-86
?
TABLE A.5-18 GRASS-GCAT-MILK PA'IEWAY FACIOR p M2 MREM /YR PER uCi/sec Q TEEN -
NUCLIDE BONE LIVER T BODY THYROID KIDNEY IUNG GI-LLI H-3 0.00E-01 2.03E 03 2.03E 03 2.03E 03 2.03E 03 2.03E 03 2.03E 03 C-14 4.86E 08 9.72E 07 9.72E 07 9.72E 07 9.72E 07 9.72E 07 0.72E 07 Na-24 5.llE 05 5.llE 05 5.11E 05 5.llE 05 5.llE 05 5.llE 05 5.llE 05 P-32 3.78E 10 2.34E 09 1.47E 09 0.00E-01 0.00E-01 0.00E-01 3.18E 09 Cr-51 0.00E-01 0.00E-01 5.99E 03 3.33E 03 1.31E 03 8.55E 03 1.01E 06 .
Mn-54 0.00E-01 1.68E 06 3.34E 05 0.00E-01 5.02E 05 0.00E-01 3.45E 06 Mn-56 0.00E-02 8.85E-04 1.57E-04 0.00E-01 1.12E-03 0.00E-01 5.82E-02 Fe-55 5.79E 05 4.10E 05 9.57E 04 0.00E-01 0.00E-01 2.60E 05 1.78E 05 Fe-59 6.74E 05 1.57E 06 6.07F'05 0.00E-01 0.00E-01 4.96E 05 3.72E 06 Co-58 0.00E-01 9.52E 05 2.19E 06 0.00E-01 0.00E-01 0.00E-01 1.31E 07 00-60 0.00E-01 3.34E 06 7.52E 06 0.00E-01 0.00E-01 0.00E-01 4.35E 07 Ni-63 1.42E 09 1.00E 08 4.81E 07 0.00E-01 0.00E-01 0.00E-01 1.59E 07 Ni-65 1.02E-01 1.30E-02 5.92E-03 0.00E-01 0.00E-01 0.00E-01 7.05E-01 Cu-64 0.00E-01 4.74E 03 2.23E 03 0.00E-01 1.20E 04 0.00E-01 3.67E 05
- s. Zn-65 2.53E 08 8.78E 08 4.09E 08 0.00E-01 5.62E 08 0.00E-01 3.72E 08 Zn-69 1.15E-12 2.20E-12 1.54E-13 0.00E-01 1.44E-12 0.00E-01 4.05E-12 Br-83 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 Br-84 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 i
Br-85 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 Rb-86 0.00E-01 5.67E 08 2.67E 08 0.00E-01 0.00E-01 0.00E-01 8.40E 07 Rb-88 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 Rb-89 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 Sr-89 5.62E 09 0.00E-01 1.61E 08 0.00E-01 0.00E-01 0.00E-01 6.69E 08 Sr-90 1.39E 11 0.00E-01 3.43E 10 0.00E-01 0.00E-01 0.00E-01 3.90E 09 Sr-91 1.]lE 05 0.00E-01 4.40E 03 0.00E-01 0.00E-01 0.00E-01 5.02E 05 Sr-92 1.88E 00 0.00E-01 8.02E-02 0. 00 E-O'1 0.00E-01 0.00E-01 4.80E 01 Y-90 1.56E 01 0.00E-01 4.20E-01 0.00E-01 0.00E-01 0.00E-01 1.29E 05 Y-91M 1.33E-20 0.00E-01 5.07E-22 0.00E-01 0.00E-01 0.00E-01 6.26E-19 i
Y-91 1.90E 03 0.00E-01 5.08E 01 0.00E-01 0.00E-01 0.00E-01 7.77E 05 g
\ s) Y-92 1.24E-05 0.00E-01 3.59E-07 0.00E-01 0.00E-01 0.00E-01 3.40E-01 A-90 05-23-86 y - ,-,, ,,--_.-
- . = - . . - - _ . .
r TABLE A.5-18 (Cont'd) i GRASS-GOAT-MIIK PA'IWAY FAC'IOR s
M2 MREM /YR PER uCi/sec Em -
NUCLIDE -BONE LIVER T BODY THYROID KIDNEY LUNG GI-LLI Y-93 5.16E-02 0.00E-01 1.41E-03 0.00E-03 0.00E-01 0.00E-01 1.58E 03
- Zr-95 1.98E 02 6.25E 01 4.30E 01 0.00E-01 9.18E 01 0.00E-01 1.44E 05 i Zr-97 9.47E-02 1.87E-02 8.63E-03 0.00E-01 2.84E-02 0.00E-01 5.07E 03 6
Nb-95 - 1.69E 04 9.37E 03 5.16E 03 0.00E-01 9.09E 03 0.00E-01 4.01E 07 Mo-99 0.00E-01 5.37E 06 1.02E 06 0.00E-01 1.23E 07 0.00E-01 9.61E 06 Tc-99M- 6.92E-01 1.93E 00 2.50E 01 0.00E-01 2.88E 01 1.07E 00 1.27E 03 t
Tc-101 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0,00E-01 Ru-103 2.17E 02 0.00E-01 9.28E 01 0.00E 01 7.66E 02 0.00E-01 1.81E 04 Ru-105 1.88E-04 0.00E-01 7.30E-05 0.00E-01 2.37E-03 0.00E-01 1.52E-01 Ru-106 4.50E 03 0.00E-01 5.67E 02 0.00E-01 8.68E 03 0.00E-01 2.16E 05 i
- -Ag-110M 1.16E 07 1.09E 07 6.65E 06 0.00E-01 2.08E 07 0.00E-01 3.07E 09 -
Te-125M. 3.60E 06 1.30E 06 4.82E 05 1.01E 06 0.00E-01 0.00E-01 1.06E 07 Te-127M 1.01E 07 3.59E 06 1.20E 06 2.41E 06 4.10E 07 0.00E-01 2.52E 07 O Te-127 1.45E 02 5.15E 01 3.13E 01 1.00E 02 5.89E 02 0.00E-01 1.12E 04 V Te-129M 1.32E 07 4.90E 06 2.09E 06 4.26E 06 5.53E 07 0.00E-01 4.96E 07 Te-129 6.28E-ll 2.34E-ll 1.53E-ll 4.48E-11 2.63E-10 0.00E-01 3.43E-10 Te-131M 7.89E 04 3.78E 04 3.16E 04 5.69E 04 3.94E 05 0.00E-01 3.04E 06 -
l Te-131 8.04E-34 3.31E-34 2.51E-34 6.19E-34 3.51E-33 0.00E-01 6.60E-35
, Te-132 5.15E 05 3.26E 05 3.07E 05 3.44E 05 3.13E 06 0.00E-01 1.03E 07 I-130 8.87E 05 2.57E 06 1.02E 06 2.09E 08 3.95E 06 0.00E-01 1.97E 06 I-131 6.45E 08 9.03E 08 4.85E 08 2.63E 11 1.55E 09 0.00E-01 1.79E 08 I-132 3.51E-01 9.18E-01 3.29E-01 3.09E 01 1.45E 00 0.00E-01 4.00E-01 I-133 8.49E 06 1.44E 07 4.39E 06 2.01E 09 2.52E 07 0.00E-01 1.09E 07 I-134 4.34E-12 1.15E-11 4.13E-12 1.92E-10 1.81E-11 0.00E-01 1.51E-13 3
4 I-135 2.74E 04 7.05E 04 2.61E 04 4.54E 06 1.llE 05 0.00E-01 7.82R 04 Cs-134 2.94E 10 6.93E 10 3.22E 10 0.00E-01 2.20E 10 8.41E 09 8.62E 08 4
Cs-136 1.33E 09 5.25E 09 3.52E 09 0.00E-01 2.86E 09 4.50E 08 4.22E 08 1
Cs-137 4.02E 10 5.34E 10 1.86E 10 0.00E 10 1.82E 10 7.06E 09 7.60E 08 Cs-138 4.99E-23 9.58E-23 4.79E-23 0.00E-01 7.07E-23 8.23E-24 4.34E-26 Ba-139 1.01E-08 7.13E-12 2.95E-10 0.00E-01 6.72E-12 4.91E-12 9.04E-08 A-91 05-23-86 1
-, -*-.---,w ,,,--e...,-----:. , , - - - . ---e n ._.,we , - , . - - - . - - - - - - - - , - - , - - ~ . - - - - - - - , ,-,v. 7 ~ ---
1 TABLE A.5-18 (Cont'd)
GRASS-GOAT-MILK PA'IWAY FACIOR M2 MREM /YR PER uCi/s<r Em -
NUCLIDE BONE LIVER T BODY THYROID KIDNEY LUNG GI-LLI Ba-140 5.82E 06 7.14E 03 3.75E 05 0.00E-01 2.42E 03 4.08E 03 8.98E 06
- Ba-141 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 Ba-142 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 La-140 9.75E-01 4.79E-01 1.27E-01 0.00E-01 0.00E-01 0.00E-01 2.75E 04 La-142 2.03E-12 9.03E-13 2.25E-13 0.00E-01 0.00E-01 0.00E-01 2.75E-08 1
Ce-141 1.07E 03 7.12E 02 8.18E 01 0.00E-01 3.35E 02 0.00E-01 2.04E 06 7
Ce-143 9.17E 00 6.67E 03 7.45E-01 0.00E-01 2.99n 00 0.00E-01 2.01E 05 Ce-144 7.90E 04 3.27E 04 4.24E 03 0.00E-01 1.95E 04 0.00E-01 1.99E 07 Pr-143 3.48E 01 1.39E 00 1.73E 00 0.00E-01 8.08E 00 0.00E-01 1.15E 05 j
3 Pr-144 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 Nd-147 2.19E 01 2.38E 01 1.42E 00 0.00E-01 1.40E 01 0.00E-01 8.57E 04 W'-187 1.44E 03 1.17E 03 4.11E 02 0.00E-01 0.00E-01 0.00E-01 3.18E 05 b NP-239 8.41E-01 7.93E-02 4.41E-02 0.00E-01 2.49E-01 0.00E-01 1.28E 04
- Og d
i 4
k v
A-92 05-23-86
7 TABLE A.5-19 GRASS-GQAT-MILK PA'IWAY FACTOR q M2 MPDVYR PER uCi/sec CHILD ~
NUCLIDE BONE LIVER T BODY 'IRYROID KIDhTY LUNG GI-LLI H-3 0.00E-01 3.20E 03 3.20E 03 3.20E 03 3.20E 03 3.20E 03 3.20E 03 0-14 1.19E 09 2.39E 08 2.39E 08 2.30E 08 2.39E 08 Na-24 2.39E 08 2.39E 08 1.06E 06 1.06E 06 1.06E 06 1.06E 06 1.06E 06 1.06E 06 1.06E 06 P-32 9.33E 10 4.37E 09 3.60E 09 0.00E-01 0.00E-01 0.00E-01 2.58E 09 Cr-51 0.00E-01 0.00E-01 1.22E 04 6.78E 03 1.85E 03 Mn-54 1.24E 04 6.48E 05 I
0.00E-01 2.52E 06 6.70E 05 0.00E-01 7.06E 05 0.00E-01 2.llE 06 Mn-56 0.00E-01 1.54E-03 3.48E-04 0.00E-01 1.87E-03 0.00E-01 2.24E-01 Fe-55 1.45E 06 7.70E 05 2.39E 05 0.00E-01 0.00E-01 Fe-59 4.36E 05 1.43E 05 1.56E 06 2.53E 06 1.26E 06 0.00E-01 0.00E-01 7.33E 05 2.63E 06 Co-58 0.00E-01 1.46E 06 4.45E 06 0.00E-01 0.00E-01 0.00E-01 8.49E 06 Co-60 0.00E-01 5.18E 06 1.53E 07 0.00E-01 0.00E-01 0.00E-01 2.87E 07 Ni-63 3.56E 09 1.90E 08 1.21E 08 0.00E-01 0.00E-01 0.00E-01 1.28E 07 Ni-65 2.49E-01 2.34E-02 1.37E-02 0.00E-01 0.00E-01 0.00E-01 2.87E 00 0.00E-01 8.23E 03 5.03E 03 0.00E-01 2.01E 04 0.00E-01 0'1Cu-64 Zn-65 4.96E 08 1.32E 09 8.22E 08 0.00E-01 8.33E 08 0.00E-01 3.91E 05 2.32E 08 2n-69 2.84E-12 4.10E-12 3.79E-13 0.00E-01 2.49E-12 0.00E-01 2.58E-10 Br-83 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 Br-84 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 Br-85 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 Rb-86 0.00E-01 0.00E--01 1.05E 09 6.47E 08 0.00E-01 0.00E-01 0.00E-01 6.77E 07 Rb-88 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 4
Rb-89 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 Sr-89 1.39E 10 0.00E-01 3.97E 08 0.00E-01 0.00E-01 0.00E-01 Sr-90 5.38E 08
, 2.35E 11 0.00E-01 5.95E 10 0.00E-01 0.00E-01 0.00E-01 3.16E 09 Sr-91 2.71E 05 0.00E-01 1.02E 04 0.00E-01 0.00E-01 0.00E-01 Sr-92 5.99E 05 4.60E 00 0.00E-01 1.84E-01 0.00E-01 0.00E-01 0.00E-01 8.71E 01 Y-90 3.86E 01 0.00E-01 1.03E-00 0.00E-01 0.00E-01 0.00E-01 1.10E 05 Y-91M 3.24E-20 0.00E-01 1.18E-21 0.00E-01 0.00E-01 0.00E-01 6.34E-17 q Y-91 4.68E 03 0.00E-01 1.25E 00 0.00E-01 0.00E-01 0.00E-01 6.24E 05 Y-92 3.04E-05 0.00E-01 8.71E-07 0.00E-01 0.00E-01 0.00E-01 8.79E-01 A-93 05-23-86
__ _ 1 _ _
- - - - - --- - - --- L -
t TABLE A.5-19 (Cont'd) p GRASS-GOAT-MILK PATHWAY FACIOR M2 MREM /YR PER uCi/sec CHILD -
NUCLIDE BONE LIVER T BODY THYROID KIDNEY LUNG GI-LLI Y-93 1.27E-01 0.00 E-01 3.48E-03 0.00E-01 0.00E-01 0.00E-01 1.89E 03
- Zr-95 4.60E 02 1.01E 02 9.00E 01 0.00E-01 1.45E 02 0.00E-01 1.05E 05 Zr-97 2.30E-01 3.33E-02 1.96E-02 0.00E-01 4.78E-02 0.00E-01 5.04E 03 l
Nb-95 3.82E 04 1.49E 04 1.06E 04 0.00E-01 1.40E 04 0.00E-01 2.75E 07 Mo-99 0.00E-01 9.76E 06 2.42E 06 0.00E-01 2.08E 07 0.00E-01 8.07E 06 Tt-99M 1.59E 00 3.llE 00 5.16E 01 0.00E-01 4.52E 01 1.58E 00 1.77E 03 i
1 1
Tc-101 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 Ru-103 5.14E 02 0.00E-01 1.97E 02 0.00E-01 1.29E 03 0.00E-01 1.33E 04 Ru-105 4.59E-04 0.00E-01 1.67E-04 0.00E-01 4.04E-03 0.00E-01 3.00E-01 Pu-106 1.llE 04 0.00E-01 1.38E 03 0.00E-01 1.50E 04 0.00E-01 1.72E 05 Ag-110M 2.51E 07 1.69E 07 1.35E 07 0.00E-01 3.15E 07 0.00E-01 2.01E 09 Te-125M 8.85E 06 2.40E 06 1.18E 06 2.48E 06 0.00E-01 0.00E-01 8.54E 06 Te-127M 2.50E 07 6.72E 06 2.96E 06 5.97E 06 7.12E 07 0.00E-01 2.02E 07 j Te-127 3.57E 02 9.64E 01 7.67E 01 2.47E 02 1.02E 03 0.00E-01 1.40E 04 Te-129M 3.26E 07 9.09E 06 3.05E 06 1.05E 07 9.56E 07 0.00E-01 3.97E 07 Te-129 1.55E-10 4.32E-ll 3.68E-ll 1.llE-10 4.53E-10 0.00E-01 9.64E-09
, Te-131M 1.92E 05 6.64E 04 7.07E 04 1.37E 05 6.43E 05 0.00E-01 2.69E 06 Te-131 1.97E-33 6.01E-34 5.87E-34 1.51E-33 5.97E-33 0.00E-01 1.04E-32 Te-132 1.23E 06 5.44E 05 6.58E 05 7.93E 05 5.05E 06 0.00E-01 5.48E 06 I-130 2.07E 06 4.19E 06 2.16E 06 4.62E 08 6.27E 06 0.00E-01 1.96E 06 I-131 1.56E 09 1.57E 09 8.94E 08 5.20E 11 2.58E 09 0.00E-01 1.40E 08 I-132 8.30E-01 1.52E 00 7.01E-01 7.07E 01 2.33E 00 0.00E-01 1.79E 00 ;
I-133 2.06E 07 2.55E 07 9.65E 06 4.74E 09 4.25E 07 0.00E-01 1.03E 0'7 I-134 1.03E-ll 1.91E-ll 8.77E-12 4.39E-10 2.92E-11 0.00E-01 1.26E-]l 3
I-135 6.49E 04 1.17E 05 5.52E 04 1.03E 07 1.79E 05 3.00E-01 8.90E 04 Cs-134 6.79E 10 1.llE 11 2.35E 10 0.00E-01 3.45E 10 1.24E 10 6.01E 08 Cs-136 3.01E 09 8.27E 09 5.35E 09 0.00E-01 4.40E 09 6.57E 08 2.91E 08 Ca-137 9.67E 10 9.26E 10 1.37E 10 0.00E-01 3.02E 10 1.09E 10 5.80E 08
, , Cs-138 1.21E-22 1.68E-22 1.07E-22 0.00E-01 1.18E-22 1.27E-23 7.74E-23 i Ba-139 2.49E-08 1.33E-ll 7.21E-10 0.00E-01 1.16E-11 7.82E-12 1.44E-06 i
A-94 05-23-86
?
TABLE A.5-19 (Cont 'd)
GN30AT-MILK PA'ITMAY FACIOR
/ T M2 MREM /YR PER uCi/sec C' CHILD '
NUCLIDE BONE LIVER T BODY THYROID KIDIEY LUNG GI-LLI Ba-140 1.41E 07 1.23E 04 8.21E 05 0.00E-01 4.01E 03 7.34E 03 7.12E 06 Ba-141 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 Ba-142 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 La-140 2.33E 00 8.16E-01 2.75E-01 0.00E-01 0.00E-01 0.00E-01 2.27E 04 La-142 4.91E-12 1.56E-12 4.90E-13 0.00E-01 0.00E-01 0.00E-01 3.10E-07 Ce-141 2.63E 03 1.31E 03 1.94E 02 0.00E-01 5.74E 02 0.00E-01 1.63E 06 Ce-143 2.25E 01 1.22E 04 1.77E 00 0.00E-01 5.12E 00 0.00E-01 1.79E 05 Ce-144 1.95E 05 6.llE 04 1.04E 04 0.00E-01 3.38E 04 0.00E-01 1.59E 07 Pr-143 8.62E 01 2.59E 01 4.28E 00 0.00E-01 1.40E 01 0.00E-01 9.30E 04 Pr-144 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 Nd-147 5.36E 01 4.34E 01 3.36E 00 0.00E-01 2.38E 01 0.'0E-01 6.88E 04 W-187 3.49E 03 2.07E 03 9.28E 02 0.00E-01 0.00E-01 0.00E-01 2.19E 05 FD N,-23, 2.e7e ee 1.4ee-e1 1.e4e-e1 e.eDe-e1 4.30e-01 0.eeE-e1 1.1ee e4 4
- s S
A-95 05-23-86
t TABLE A.5-20 GRASS-GOAT-MILK PA'IEWAY FACTOR M2 MREM /YR PER uCi/sec _
INFANT -
NUCLIDE BONE LIVER T BODY THYROID KIDNEY LUNG GI-LLI H-3 0.00E-01 4.86E 03 4.86E 03 4.86E 03 4.86E 03 4.86E 03 4.86E 03 C-14 2.34E 09 5.00E 08 5.00E 08 5.00E 08 5.00E 08 5.00E 08 5.00E 08 Na-24 1.85E 06 1.85E 06 1.85E 06 1.85E 06 1.85E 06 1.85E 06 1.85E 06 P-32 1.92E 11 1.13E 10 7.45E 09 0.00E-01 0.00E-01 0.00E-01 2.60E 09 Cr-51 0.00E-01 0.00E-01 1.94E 04 1.26E 04 2.76E 03 2.46E 04 Mn-54 5.64E 05 0.00E-01 4.68E 06 1.06E 06 0.00 E-01 1.04E 06 0.00E-01 1.72E 06 Mn-56 0.00E-01 3.78E-03 6.51E-04 0.00E-01 3.25E-03 0.00E-01 3.43E-01 Fe-55 1.76E 06 1.13E 06 3.03E 06 0.00E-01 0.00E-01 5.54E 05 Fe-59 1.44E 05 2.92E 06 5.09E 06 2.01E 06 0.00E-01 0.00E-01 1.51E 06 2.43E 06 00-58 0.00E-01 2.91E 06 7.26E 06 0.00E-01 0.00E-01 0.00E-01 Co-60 7.25E 06 0.00E-01 1.06E 07 2.50E 07 0.00E-01 0.00E-01 0.00E-01 2.52E 07 Ni-63 4.19E 09 2.59E 08 1.45E 08 0.00E-01 0.00E-01 0.00E-01 1.29E 07
/~'* Ni-65 5.27E-01 5.96E-02 2.71E-02 0.00E-01 0.00E-01 0.00E-01 4.54E 00
( Cu-64 0.00E-01 2.07E 04 9.58E 03 0.00E-01 3.50E 04 0.00E-01 4.25E 05 Zn-65 6.66E 08 2.28E 09 1.05E 09 0.00E-01 1.llE 09 0.00E-01 1.93E 09 Zn-69 6.04E-12 1.09E-11 8.10E-13 0.00E-01 4.52E-12 0.00E-01 8.87E-10 Er-83 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 Br-84 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01
{ Br-85 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 Rb-86 0.00E-01 0.00E-01 2.67E 09 1.32E 09 0.00E-01 0.00E-01 0.00E-01 6.83E 07 Rb-88 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01
. Rb-89 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01
! 0.00E-01 Sr-89 2.64E 10 0.00 E-01 7.58E 08 0.00E-01 0.00E-01 0.00E-01 Sr-90 5.43E 08 2.55E 11 0.00E-01 6.50E 10 0.00E-01 0.00E-01 0.00E-01 3.19E 09 Sr-91 5.65E 05 0.00E-01 2.05E 03 0.00E-01 0.00E-01 0.00E-01 Sr-92 6.69E 05 9.76E 00 0.00E-01 3.63E-01 0.00E-01 0.00E-01 0.00E-01 1.05E 02 Y-90 8.16E 01 0.00E-01 2.19E 00 0.00E-01 0.00E-01 0.00E-01 1.13E 05 Y-91M 6.87E-20 0.00E-01 2.34E-21 0.00E-01 0.00E-01
'l 0.00E-01 2.29 E-16
' (' Y-91 Y-92 8.79E 03 0.00E-01 6.47E-05 0.00E-01 2.34E 02 1.82E-06 0.00E-01 0.00E-01 0.00E-01 0.00E-01 6.30E 05 0.00E-01 0.00E-01 1.23E 00 A-96 '
05-23-86
?
TABLE A.5-20 (Cont 'd) i 4 --
GRASS-GQAT-MILK PATHWAY FACTOR
! M2 MREM /YR PER uCi/sec INFANT NUCLICE BONE LIVER T BODY THYPOID KIDNEY LUNG GI-LLI 2
Y 2.70E-01 0.00E-01 -7.36E-03 0.00E-01 0.00E-01 0.00E-01 2.13E 03 i Zr-95 8.17E 02 1.998 02 1.41E 02 0.00E-01 2.14E 02 0.00E-01 9.91E 04 Zr-97 4.88E-01 8.37E-02 3.82E-02 0.00E-01 8.44E-02 0.00E-01 5.34E 03 Nb-95 7.12E 04 2.93E 04 1.70E 04 0.00E-01 2.10E 04 0.00E-01 2.48E 07 Mo-99 0.00E-01 2.50E 07 4.87E 06 0.00E-01 3.73E 07 0.00E-01 8.22E 06
, 7t-99M 3.30E 00 6.81E 00 8.77E 01 0.00E 01 7.33E 01 3.56E 00 1.98E 03 i
- Tt-101 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 Ru-103 1.04E 03 0.00E-01 3.48E 02 0.00E-01 2.16E 03 0.00E-01 1.26E 04 ,
, Ru-105 9.68E-04 0.00E-01 3.26E-04 0.00E-01 7.12E-03 0.00E-01 3.85E-01
- -Ru-106 2.28E 04 0.00E-01 2.85E 03 0.00E-01 2.70E 04 0.00E-01 1.73E 05 Ag-110M 4.63E 07 3.38E 07 2.24E 07 0.00E-01 4.83E 07 0.00E-01 1.75E 09-j Te-125M 1.81E 07 6.05E 06 2.45E 06 6.09E 06 0.00E-01 0.00E-01 8.62E 06
- Te-127M 5.05E 07 1.68E 07 6.12E 06 1.46E 07 1.24E 08 0.00E-01 2.04E 07 j Te-127 7.59E 02 2.54E 02 1.63E 02 6.18E 02 1.85E 03 0.00E-01 1.59E 04 i
Tu-129M 6.69E 07 2.29E 07 1.03E 07 2.57E 07 1.67E 08 0.00E-01 3.99E 07 i
j Te-129 3.28E-10 1.13 E-10 7.66E-11 2.75E-10 8.17E-10 0.00E-01 2.62E-08 l
Tb-131M 4.05E 05 1.63E 05 1.35E 05 3.31E 05 1.12E 06 0.00E-01 2.75E 06 Te-131 4.18E-33 1.54E-33 1.17E-33 3.73E-33 1.07E-32 0.00E-01 1.69E-31 Tb-132 2.53E 06 1.25E 06 1.17E 06 1.85E 06 7.84E 06 0.00E-01 4.64E 06 I-130 4.26E 06 9.38E 06 3.76E 06 1.05E 09 1.03E 07 0.00E-01 2.01E 06 I-131 3.26E 09 3.85E 09 1.69E 09 1.26E 12 4.49E 09 0.00E-01 1.37E 08 l I-132 1.72E 00 3.49E 00 1.24E 00 1.64E 02 3.90E 00 0.00E-01 2.83E 00 l I-133 4.35E 07 6.34E 07 1.86E 07 1.15E 10 7.45E 07 0.00E-01 1.07E 07 i I-134 2.13E-11 4.36E 1.55E-ll 1.02E-09 4.88 E-11 0.00E-01 4.51E-ll l
i I-135 1.35E 05 2.68E 05 9.79E 04 2.41E 07 2.99E 05 0.00E-01 9.71E 04 Cs-134 1.09E 11 2.04E 11 2.06E 10 0.00E-01 5.25E 10 1.86E 10 5.54E 08 Cs-136 5.88E 09 1.73E 10 6.45E 09 0.00E-01 6.89E 09 1.41E 09 2.63E 08 Cs-137 1.54E 11 1.81E 11 1.28E 10 0.00E-01 4.85E 10 1.96E 10 5.65E 08 !
l Cs-138 2.55E-22 4.15E-22 2.01E-22 0.00E-01 2.07E-22 3.23E-23 6.63E-22
( Ba-139 5.30E-08 '3.51E-11 1.53E-09 0.00E-01 2.11E-11 2.13E-11 3.35E-06 .
l i
A-97 05-23-86 J . .
. _ _ . .-. _ _ . . . - . = . . . _ _ _ . . . . _ _
v
. TABLE A.5-20 (Cont 'd)
GRASS-COAT-MIIK PATHWAY FACICR
^')/
M2 MREM /YR PER uCi/sec INFAN'r -
NUCLIDE BONE LIVER T BODY THYROID KIDNEY LUNG GI-LLI Ba-140 2.89E 07 2.89E 04 1.49E 06 0.00E-01 6.87E 03 1.78E 04 7.llE 06 Ba-141 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 Ba-142 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 La-140 4.88E 00 1.92E 00 4.94E-01 0.00E-01 0.00E-01 0.00E-01 2.26E 04 La-142 1.03E-ll 3.78E-12 9.06E-13 0.00E-01 0.00E-01 0.00E-01 6.43E-07 i Ce-141 5.20E 03 3.17E 03 3.74E 02 0.00E-01 9.79E 02 0.00E-01 1.64E 06 i
Ce-143 4.76E 01 3.16E 04 3.61E 00 0.00E-01 9.21E 00 0.00E-01 1.84E 05 Ce-144 2.79E 05 1.14E 05 1.56E 04 0.00E-01 4.62E 04 0.00E-01 1.60E 07 Pr-143 1.78E 02 6.67E 01 8.84E 00 0.00E-01 2.48E 01 0.00E-01 9.41E 04 Pr-144 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 0.00E-01 Nd-147 1.06E 02 1.09E 02 6.69E 00 0.00E-01 4.21E 01 0.00E-01 6.92E 04 W-187 7.35E 03 5.11E 03 1.77E 03 0.00E-01 0.00E-01 0.00E-01 3.00E 05 Np-239 4.38E C0 3.91E-01 2.21E-01 0.00E-01 7.80E-01 0.00E-01 1.13E 04
.)
l l
1 O
- A-98 05-23-86
KANSAS GAS AND ELECTRIC COMPANY THE ELECTNC COMPANY August 29, 1986 GLENN L KOESTER vca petssoggy muctgan Document Control Desk U.S. Nuclear Regulatory Commission Washington, D.C. 20555 Mr. R. D. Martin, Regional Administrator U.S. Nuclear Regulatory Commission Region IV 611 Ryan Plaza Drive, Suite 1000 Arlington, Texas 76011 KMLNRC 86-157 Re: Docket No. STN 50-482 Subj: Semiannual Radiological Effluent Release Report Gentlemen:
Enclosed is the Welf Creek Generating Station Semiannual Radiological Effluent Release Report covering the period from January 1, 1986, through June 30, 1986. This report is submitted pursuant to section 6.9.1.7 of the Wolf Creek Generating Station Unit 1 Technical Specifications.
Yours very truly, t9Abfbb Glenn L. Koester Vice President - Nuclear GLK:see cc: P0'Connor (2), w/a JTaylor, w/a JCummins, w/a
/
O 9
l
,(f 7 \\
i I
201 N. Market - Wictuta, Kansas - Man Address: PO. Box 208 I Wichita. Kansas bl?01 - Telephone: Area Code (316) 261-6451